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CHAPTER 1. INTRODUCTION 
Objective 
 Porcine circovirus type 2 (PCV2) has been divided into two subtypes based on the 
nucleotide sequence of the capsid protein.  These subtypes are now commonly referred to as 
PCV2a and PCV2b.  The current scientific literature has conflicting reports about the 
differences in pathogenicity or virulence between these PCV2 subtypes.  Because of the 
difficulty in obtaining PCV2 negative pigs and reproducing PCV2 associated disease 
experimentally, development of experimental models for this disease has been challenging. 
The objectives of this thesis were to evaluate the effect of a PCV2a and PCV2b dose 
response, and to compare the pathogenesis, leukograms and immune response in gnotobiotic 
pigs inoculated with PCV2a and PCV2b.  Differences in PCV2 viremia and antibody levels 
were determined for pigs with and without disease regardless of the PCV2 type used for 
inoculation. 
Thesis Organization 
 This thesis consists of a general introduction, literature review, two chapters 
representing research submitted for publication and a general summary. 
Statement of the Problem 
 PCV2 has become an important viral pathogen in swine populations around the 
world.  Evidence suggests that PCV2 has been present in pigs for at least 40 years, but did 
not appear to be associated with clinical disease until the early 1990’s.  PCV2 is the causative 
agent of porcine circovirus associated disease (PCVAD) of which one clinical expression is 
post weaning multisystemic wasting syndrome (PMWS).  Canadian swine herds, primarily in 
Ontario and Quebec, began to experience mortality rates 2 to 3 times above the normal 
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average mortality rate in the Fall of 2004.  A similar scenario began to occur in the 
Southeastern United States approximately one year later.  Large quantities of PCV2 were 
consistently found in pigs submitted to various diagnostic labs from farms experiencing 
higher than normal mortality rates suggesting a link between PCV2 and the clinical signs and 
mortality.  Viral genome sequencing determined that a new PCV2 subtype not previously 
identified in North America was present in these herds.  This subtype, known as PCV2b, was 
similar to isolates previously recovered in Europe and Asia and had not been isolated in the 
U.S before 2006.   
 Reports have suggested that PCV2b is more pathogenic than PCV2a, although there 
has been minimal evidence to support this theory within the scientific literature.  Additional 
studies are needed to characterize potential differences in the pathogenesis between these two 
genetically different PCV2 subtypes currently circulating in the U.S. swine population.  
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CHAPTER 2. LITERATURE REVIEW 
Introduction 
 Porcine Circovirus type 2 (PCV2) is the causative agent of porcine circovirus 
associated disease (PCVAD) which includes post-weaning multisystemic wasting syndrome 
(PMWS).16,35,38  PCV2 has been isolated throughout the world and is now one of the most 
economically important diseases in swine.  The National Animal Health Monitoring System 
(NAHMS) 2006 survey found PCVAD to be the seventh most commonly reported disease 
problem in the U.S. in nursery-aged pigs (http://nahms.aphis.usda.gov/index.htm).  PCVAD 
was the fifth most commonly reported disease problem in grow/finish pigs compared to 
being fifteenth in the NAHMS 2000 survey (http://nahms.aphis.usda.gov/index.htm).  In 
2006, 22.3% of farms with nursery-aged pigs reported PCVAD as a problem compared to 
only 5.7% of farms in the 2000 NAHMS survey.   Larger operations with nursery-aged pigs 
were more likely to report PCVAD as a problem (39.6%) compared to medium (12.5%) and 
small operations (21.5%).  Overall, 31.3% of the swine operations with grower and finisher 
pigs reported PCVAD as a problem in 2006 compared to only 3.6% of the operations in 
2000.  Larger operations were again more likely to identify PCVAD as a problem (59.9%) 
than medium (35.4%) or small swine operations (25.0%). 
Virology 
PCV1 / PCV2 
 Porcine Circovirus (PCV) is a small, circular, single stranded DNA virus.96  The virus 
is non-enveloped with icosahedral symmetry and a diameter of 17 nm.   PCV contains an 
ambisense genome of approximately 1.76 kb which makes it the smallest virus known to 
infect swine.96   
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 PCV is classified as a member of the family Circoviridae which is divided into two 
genera. 96  The genus Circovirus includes the following species: psittacine beak and feather 
disease virus, canary circovirus, goose circovirus and pigeon circovirus.61,101  The second 
genus, known as Gyrovirus, contains only the chicken anemia virus 61,101  Porcine circovirus 
is thought to have originated from a plant virus which recombined with viruses infecting 
vertebrates.28 
 PCV was isolated as a non-cytopathic contaminant of the porcine kidney cell line PK-
15 (ATCC-CCL31) in 1974.99  Experimental challenge of pigs using this isolate did not 
produce lesions or cause disease.6,97  A variant strain of PCV was discovered in 1998 
associated with a new disease syndrome known as post-weaning multisystemic wasting 
syndrome (PMWS).2,16,23,37  This virus, designated porcine circovirus type 2 (PCV2), was 
antigenically and genetically distinct from the PK-15 contaminant, which was named porcine 
circovirus type 1 (PCV1).57  Shortly after PCV2 was isolated from pigs in Canada, reports of 
a wasting disease associated with the recovery of PCV2 were identified in the U.S.,8 
France,53 Spain,92 Northern Ireland43 and throughout Europe,8,54 and Asia.3  PCV2 has been 
reported in all swine producing countries throughout the world.  It is now known that PCV2 
was present in swine herds prior to any observed clinical disease.  For example, PCV2 was 
identified retrospectively in tissues from 1970 in the United Kingdom.31  
 Genomic DNA of PCV1 ranges between 1,758 to 1,760 base pairs (bp) and the 
genome of PCV2 is approximately 1,767-1,768 bp.25 Genomic comparison between PCV1 
and PCV2 revealed a 68-76% sequence homology.34,54,57,60  PCV1 isolates have 97-99% 
sequence homology and PCV2 isolates have 94.6-99% sequence homology within the 
species.20,25  Two main viral genes represent 93% of the PCV2 genome and consist of open 
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reading frame (ORF) 1 or the replication initiator protein (rep) and ORF 2 or the capsid 
protein (cap).20  The capsid gene has more genetic variability than the replication gene.15   
PCV2a / PCV2b 
 Experimental evidence depicting differences at either the genotypic or phenotypic 
levels between PCV2 isolates has not been well substantiated, even though previous 
phylogenetic analysis of isolates from various countries were divided into 2 main groups.20,25  
One analysis found that the U.S. and Canadian isolates were grouped more closely together 
compared to 2 French isolates which formed a minor branch that diverged from other PCV2 
isolates used in the study.25  A recent, more extensive phylogenetic analysis of 148 PCV2 
isolates taken from the NCBI nucleotide database (http://www.ncbi.nlm.nih.gov) identified 2 
major clusters of isolates.  The PCV2 clusters were labeled as group 1 which contained 3 
clades (1A-1C) and group 2 which contained 5 clades (2A-2E).65  Interestingly, the report 
identifying these 2 genotypic groups was published after a sudden increase in PCVAD was 
reported in Canada in 2004.21  The increase in PCVAD in Canada was associated with an 
increase in the identification of the restriction fragment length polymorphism (RFLP) pattern 
321 in viruses as opposed to the usual RFLP pattern 422 suggesting a possible change in the 
genotype of PCV2 isolates.21  Evidence of strain variation between PCV2 isolates was 
reported shortly thereafter with the subsequent designation of two genotypically different 
PCV2 subtypes 15,27  Adopting the nomenclature from Olvera et al. (2007), PCV2 group 1 
isolates aligned themselves phylogenetically with earlier isolates from Europe and were 
identified as PCV2b.15,27,42,71  Conversely, PCV2 group 2 isolates were phylogenetically 
more similar to North American isolates and were termed PCV2a.15,27,42,71  Differing RFLP 
patterns observed with the two subtypes were given a similar designation.  RFLP pattern 422 
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has typically been linked with PCV2a whereas RFLP pattern 321 can be linked with either 
PCV2 subtypes and requires additional genetic sequencing to verify the appropriate 
grouping.71 
 An interesting study used the genetic sequences from 133 PCV2a and PCV2b 
isolates, including 23 isolates that had been sequenced in the study, for phylogenetic 
analysis.15  The results indicated several distinct characteristics between the two subtypes 
including that all of the PCV2a isolates from field samples were 1768 nucleotides long while 
all of the PCV2b isolates were 1767 nucleotides.  Further analysis utilizing full genomic 
sequences or sequences from the capsid protein determined that the capsid genes can be used 
to separate the PCV2 isolates into 2 groups.  Based on this information, a signature motif of 
distinct nucleotide or amino acid sequences was proposed for PCV2 genotype grouping.  
This study found the nucleotide sequence at position 1487-1473 in PCV2a and 1486-1472 in 
PCV2b contained 7 different nucleotides corresponding to 4 amino acid changes within the 
capsid protein of each subtype.15  The role of these genetic changes on the structure or 
function of the capsid protein has not been established at this time. 
Pathogenesis 
  PCV2 was originally associated as a wasting disorder in pigs known as PMWS.2,5,23  
PMWS was first described in high health status swine herds in Canada in 1991 and became 
recognized as a wide spread disease by 1996.2,16,23,35  Clinical disease typically occurs in pigs 
4-16 weeks of age and is characterized by weight loss, cachexia, tachypnea, unthriftiness, 
dyspnea, diarrhea and jaundice.2,8,37,53,92  In addition to the clinical signs, a diagnosis of 
PMWS requires the presence of characteristic microscopic lesions such as lymphoid 
depletion and histiocytic replacement of depleted follicles as well as identification of PCV2 
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antigen in these lesions.94  Morbidity and mortality ranges between 4-30% or higher and is 
influenced by a number of factors including the individual farm, husbandry, management 
practices and coinfections.  Typically 70-80% of severely affected pigs will die.  Mortality 
rates in affected herds vary between 4-20%. 15,42,87 Infection with PCV2 is the cause of 
several other disease syndromes and PCV2 antigen can be found in organs other than 
lymphoid tissues.  Other syndromes that have been linked to PCV2 infection include porcine 
dermatitis and nephropathy syndrome (PDNS),82 reproductive failure,103 hepatitis,80 and 
enteritis.45  The term porcine circovirus associated disease was created to summarize all 
disease scenarios associated with PCV2.  In cases where abundant PCV2 antigen is 
associated with only 1 organ system, the disease is specifically referred to that particular 
organ system affected, i.e. PCV2-associated respiratory disease, PCV2-associated enteritis, 
etc.71 
 PCVAD became a primary concern for Canadian swine producers in 2004 when an 
acute onset of high mortality was associated with identification of PCV2 in pig herds in 
several provinces.  The University of Guelph Animal Health Laboratory (AHL) Newsletter 
was the first to report an increase in the diagnosis of PCVAD in 2005 when compared to the 
number of PCV2-associated cases over the past 7 years.21  Although many of the cases were 
associated with other pathogens, all cases had the presence of PCV2 in common.  At 
approximately the same time, producers in the U.S. began to experience a similar scenario in 
swine herds.  Mortality rates on the affected farms ranged from 5 to 50% in a given barn of 
pigs with case mortality rates reaching 100% as pigs were either euthanized or culled due to 
poor performance.9,41  The onset of disease in these herds occurred later in the finishing 
phase (4 to 6 weeks post placement in the finisher).  Mortality rates were often 2 to 3 times 
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the expected weekly rate often in the absence of other swine pathogens such as porcine 
reproductive and respiratory syndrome (PRRS), swine influenza virus (SIV) and 
Mycoplasma hyopneumoniae.  Pigs became unthrifty, anorexic, dyspneic and lethargic and 
treatment was generally unsuccessful in most of the affected animals.51   
 Researchers did not have an explanation for the increase in PCVAD in PCV2 infected 
swine herds despite high levels of PCV2 antibodies.  Two theories were proposed in an effort 
to explain this phenomenon. The theories included the hypothesis that a new, unknown 
pathogen was acting as a cofactor resulting in an increase of pigs exhibiting severe PCVAD 
and a secondary theory proposed the emergence of a new, more pathogenic strain of PCV2 in 
North American swine populations.27  Suggested cofactors associated with severe PCVAD 
include PRRSV, Mycoplasma hyopneumoniae, porcine enterovirus, porcine respiratory 
coronavirus, porcine teschovirus, bovine virus diarrhea virus and porcine endogenous 
retroviruses.15,74   
 Research has recently started to investigate pathogenic differences between PCV2a 
and PCV2b.  In one study, gnotobiotic pigs were inoculated with a PCV2b generated from an 
infectious clone.  Four of four pigs inoculated with PCV2b exhibited severe macroscopic and 
microscopic lesions consistent with PCV2 and died. In contrast, only 1 of 4 pigs administered 
the PCV2a appeared clinically affected and died on day 35 post infection. Due to the small 
number of pigs used in the study, further research is needed to confirm the relationship 
between severe PCVAD and PCV2b as well as determining the influence of cofactors, either 
infectious or intrinsic, on the severity of disease and the pathogenesis of this emerging virus. 
 Although individual pigs can be severely affected by PCV2, other pigs within the 
same group often remain unaffected.   Low amounts of PCV2 antigen with minimal lesions 
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have been demonstrated in PCV2 infected pigs that appear clinically normal.6,69,72  Therefore, 
the presence of PCV2 does not guarantee the development of disease on an individual basis. 
 PCV2 has been shown to be horizontally transmitted to naïve pigs from infected pigs 
via the oronasal route through direct contact with respiratory secretions, feces and urine.11,87  
Bolin et al. (2001), were able to demonstrate transmission of PCV2 to susceptible pigs after 
comingling them with pigs that had been infected 42 days prior to contact. PCV2 nucleic 
acids have been detected in tonsillar, nasal, tracheobronchial, urinary and fecal swabs 
collected from pigs exhibiting either clinical PCVAD or healthy.89  Vertical transmission has 
also been confirmed by the isolation of PCV2 from aborted piglets collected from a farm 
experiencing late-term abortions and stillbirths in the absence of other infectious agents.103 
 PCV2 has been shown to persist in pigs that originated from PMWS or non-PMWS 
affected herds, although the mechanism for persistence is currently unknown.52,87  In one 
study, PCV2 nucleic acids were detected 125 days post inoculation in experimentally 
infected pigs that had elevated body temperatures and reduced weight gain but did not 
develop PCVAD.11  PCV2 nucleic acids were also isolated from blood of gnotobiotic pigs 
infected with PCV2 in the presence of antibodies providing additional evidence that PCV2 
can persist within the pig while evading the immune system.49  In addition, there have been 
reports of PCV2 detected in serum and tissues at necropsy at 32 and 70 days post 
inoculation.39,49,83 
 PCV2 antigen has been found in macrophages and monocytic cells but replication in 
these cell subsets appears to be minimal.29,105  It has been proposed that PCV2 can persist in 
macrophages and monocytes inoculated in vitro due to the lack of stimuli, such as interferon 
gamma, that would typically be secreted from acutely infected cells in vivo.  Thus,  
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macrophages are not activated to destroy the virus which subsequently retains its infectious 
capability.29  More specifically, it is possible that PCV2 inhibits endosomal maturation 
pathways that would result in degradation of the virus.  Ultimately, macrophages are used as 
a vehicle for dissemination of the virus throughout the host.  Dendritic cells are considered to 
perform a similar role as macrophages in the dispersal of virus throughout the body serving 
as a vehicle for transport without destruction of virus infectivity.102 Although lymphoid 
depletion is a consistent feature of PCV2 infection, evidence for replication was lacking in 
this immune cell 29 until recent reports have shown that PCV2 capsid mRNA transcripts and 
levels of viral DNA were consistently higher in subsets of enriched T lymphocytes compared 
to monocyte and macrophage enriched cells providing evidence for replication in 
lymphocytes.104,105  An additional study by the same authors showed that the level of viral 
replication was higher in B lymphocytes isolated from the tracheobronchial lymph nodes 
from PCV2-infected pigs when compared to macrophages or monocytes.104,105 
 The exact pathogenesis of PCV2 infection and disease remains unknown although it 
is generally accepted that PCV2 infection is influenced by several factors.  These include: 
virus dependent factors such as the difference in virulence between various PCV2 isolates,70 
host-dependent factors such as the degree of susceptibility to infection and disease severity 
between different breeds,66 the impact of coinfections, and the host immune response.71  
Further investigation is required to elucidate the mechanisms behind each of these factors 
and their importance in the development of PCVAD. 
 
 
 
 11 
Pathology 
 Macroscopic lesions associated with PCVAD are most commonly found in the 
primary and secondary lymphoid systems, lungs, liver, kidneys and intestine with varying 
degrees of severity.3,16,71,81  Gastric ulcers can be present but are an inconsistent finding.37 
 Enlarged lymph nodes are the most consistent feature in PCV2-infected pigs and 
primarily the mesenteric, inguinal, mediastinal and tracheobronchial lymph nodes are 
affected. 3,16,37,81  Frequently, the inguinal lymph nodes in clinically affected pigs are large 
enough that they are easily identified through the skin.16  Lymphoid depletion of the primary 
or secondary lymphoid tissues with subsequent infiltration with histiocytic inflammation is 
the characteristic microscopic lesion of PCV2 infection.3,71,81  Lymph nodes are most 
commonly affected with varying degrees of lymphoid depletion observed in tonsils, spleen, 
and Peyer’s patches depending on the severity of the disease.81  Specifically, microscopic 
lesions include depletion of lymphoid tissues primarily within B cell follicles and expansion 
of paracortical zones characterized by infiltration with granulomatous inflammation.24,61,77  
Numerous multinucleated giant cells can be observed with clusters of basophilic, 
intracytoplasmic inclusion bodies in monocytic cells.61  In addition, the chronic form of 
PCV2 may have severe lesions with minimal amounts of viral antigen present within the 
affected tissues as measured by immunohistochemistry (IHC).71 
  Respiratory lesions are diffuse throughout the lung tissue.  The lungs have a mottled 
tan appearance, fail to collapse, are heavy and firm or rubbery on palpation.16  PCV2-
associated respiratory disease is characterized by lymphohistiocytic to granulomatous 
interstitial pneumonia, peribronchiolar fibroplasia and mild-to-severe necrotizing and 
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ulcerative bronchiolitis.  Lesions associated with bronchiolitis can appear similar to lesions 
attributed to swine influenza virus or porcine respiratory coronavirus.71 
 Hepatic lesions may range from absent to severe in pigs with PCVAD16  and are 
characterized by a lymphocytic and histiocytic inflammatory infiltrate in the portal zones 
with necrosis, swelling and vacuolation of hepatocytes. Atrophy of the bile duct with 
subsequent regeneration may also be present.  
 Renal lesions are characterized by lymphocytic, eosinophilic and histiocytic 
infiltration into the interstitium. In addition, the peripelvic connective tissue may have white 
foci or streaks and edema.3,16,81  Lesions can be localized or scattered throughout the cortical 
and medullary regions.16  
  The incidence of PDNS is thought to be associated with PCV2 infection.21  PDNS is 
characterized by raised purple skin lesions corresponding to macules or papules which are 
typically located on the hind legs and abdomen.  The kidneys are enlarged and firm with 
petechial hemorrhages on the surface corresponding to inflamed glomeruli.89  Microscopic 
lesions consist of vasculitis associated with dermal necrosis and necrotizing and fibrinous 
glomerulonephritis.  Vascular lesions are observed systemically and can occur in any tissue, 
although dermal and renal tissues are most commonly affected.71  The lesions associated with 
PDNS in the kidneys are consistent with a type 3 hypersensitivity reaction which is 
characterized by antigen-antibody complexes within the tissues. 
 PCV2-associated reproductive failure is characterized by abortions, stillbirths, and 
fetal mummification.63,71  Pigs are born weak and fail to thrive resulting in increased 
preweaning mortality.  The heart is the primary site of PCV2 replication in fetuses and 
typically PCV2 induces a myocarditis which has been observed in aborted pigs from 
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naturally-infected sows or gilts and reproduced experimentally.85,103  Fetuses inoculated in 
utero at various times during gestation results in the development of reproductive 
abnormalities including both early- and late-term infection.  However, reproductive failure is 
not a common manifestation of PCV2 disease and typically occurs in single animals rather 
than on a herd basis. 
 PCV2-associated enteritis has become more common with the emergence of PCV2b 
in the U.S.21  In affected pigs, the intestinal mucosa appears thickened and granulomatous 
infiltrates are noted throughout the lamina propria.  Lesions can resemble chronic ileitis, 
although PCV2-associated enteritis is typically characterized by increased levels of PCV2 
antigen detected by IHC staining.  Diagnosis of enteritis associated with PCV2 infection 
requires clinical diarrhea, lesions isolated to regions within the Peyer’s patches and PCV2 
antigen or nucleic acids within affected enteric tissue71   
 Atypical lesions have been associated with recent cases of PCVAD.21,42,51  Large 
volumes of pleural and peritoneal effusion can be observed in pigs infected with PCV2b.  
The lungs may be diffusely affected with dark-red congestion, cranioventral pulmonary 
consolidation and severe interlobular pulmonary edema.  PCV2-associated enteritis is a more 
common feature of PCVAD and severe lymphadenopathy and lymphoid necrosis have also 
been reported.21     
Immunology 
Innate & Adaptive Immunity 
 The presence of opportunistic pathogens, lymphoid depletion and lymphopenia in the 
peripheral blood of PCVAD-affected pigs suggests the immune system is involved in the 
pathogenesis of PCV2.16,19,23,90  Evidence of immune suppression is based on the isolation of 
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Pneumocystis carinii from the lungs of PMWS-affected pigs 16 and a decrease in circulating 
B and T cells.18,62  In addition, PCVAD pigs may be unable to mount an effective immune 
response to many opportunistic organisms as well as typical swine pathogens.18,23,90 
 PCV2 antigen has been identified in the cytoplasm of a number of immune cell 
populations including monocytes and pulmonary macrophages, 14,29,81 monocyte-derived 
macrophages,29 dendritic cells,81,102 and lymphocytes.104,105 Virus distribution in tissues 
varies depending on the age at which infection occurs.  In utero infections are characterized 
by PCV2 in cardiomyocytes whereas macrophages and lymphocytes are the most common 
cell populations infected after birth.84,104,105   
 PCV2 replication and the cells that support this function have been extensively 
investigated in order to understand the pathogenesis of the virus.  PCV2 does not possess the 
polymerases necessary for replication; therefore it requires the use of polymerases provided 
by the nucleus of cells in the S phase of the cell cycle.98  The presence of PCV2 in the 
nucleus of a cell suggests that it supports PCV2 replication.  Early studies utilizing in situ 
hybridization and immunohistochemistry did not clearly demonstrate that lymphocytes were 
infected by PCV2 in natural or experimentally infected pigs.43,81  Theories began to change 
when PCV2 antigen and virions were detected in apoptotic bodies of B lymphocytes that had 
been phagocytosed by macrophages in severely depleted lymphoid tissue of PCVAD-
affected pigs.93  In contrast, the apoptotic rate in lymphoid tissues was evaluated using in situ 
hybridization and cleaved caspase-3 in PMWS-affected and unaffected conventional pigs.79  
The apoptotic rate in PMWS-affected pigs was inversely correlated with the severity of 
lesions and viral load in serum quantified by real-time PCR.  This suggested that apoptosis is 
not a feature of PMWS lymphoid lesions although this was not a controlled study and 
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additional factors may have influenced the results.  Another study examined gnotobiotic pigs 
with PMWS for apoptosis in both lymphoid lesions and livers.46  The authors concluded the 
only consistently positive TUNEL signal, as a measure of apoptosis, was located in the 
cytoplasm of PCV2-infected macrophages.  Therefore, it appeared apoptosis was not a 
feature of lymphoid lesions and hepatic failure in PMWS-affected gnotobiotic pigs although 
sampling may have occurred after the lymphocytes were already depleted.  Apoptosis is 
generally accepted to occur early during the course of an infection; therefore, pigs with 
severe PMWS and lymphoid depletion are likely beyond the period of optimal detection of 
apoptosis.  The acute phases of PCVAD need to be evaluated to conclude the role apoptosis 
may play in the course of the disease.   
 Recent reports have investigated the effect of PCV2 on immune cell proliferation and 
apoptosis during the early stages of infection.104,105  Using a novel approach, the authors 
developed a quantitative PCR for PCV2 spliced capsid mRNA to detect cell populations, in 
vitro and in vivo, that supported PCV2 replication.  One study indicated a strong correlation 
between the level of PCV2 capsid mRNA and the level of viral DNA in concanavalin A 
(ConA) stimulated peripheral blood mononuclear cells (PBMC).  In addition, an evaluation 
of T lymphocyte and monocyte/macrophage enriched or depleted PBMC populations 
stimulated with ConA showed significantly higher capsid mRNA and viral DNA in the T 
lymphocyte and monocyte/macrophage-depleted PBMCs than other cells indicating that 
PCV2 replicates in lymphocytes, particularly T lymphocytes, upon stimulation.  An 
additional study by the same authors evaluated the levels of spliced capsid mRNA and viral 
DNA following experimental infection of conventional pigs with PCV2.  Replication and 
viral DNA synthesis were detected in T and B lymphocyte and monocyte populations from 
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PBMCs and the bronchial lymph nodes, although replication in B lymphocytes was greater 
than observed in mononuclear cells isolated from the bronchial lymph node at 14 dpi.  These 
results indicate that B lymphocytes, as well as T lymphocytes, are important cell populations 
for PCV2 replication which may explain the decreased circulating lymphocytes and the 
lymphoid depletion common in PMWS-affected pigs. 
 Additional cells of the immune system believed to be targets for PCV2 replication 
due to the presence of viral antigen in the nuclei of these cells include monocytes and/or 
macrophages7,56,81 and antigen presenting cells.81  Recent investigations have reported a lack 
of infectious virus progeny and replication intermediates in macrophages compared to PCV2 
infected PK15 cells suggesting that monocytic cells do not support PCV2 replication.29  
Similar reports lacking evidence of PCV2 replication have been made regarding dendritic 
cells.102  Therefore, unlike lymphocytes, it appears that PCV2 does not replicate to significant 
levels in these cells types, but both monocytes/macrophages and dendritic cells serve a 
different function in the pathogenesis of PCV2.  In studies that investigated virus replication 
potential in monocytic and dendritic cells, it was found that  PCV2 can persist in these 
antigen presenting cells (APC) without causing cell death,14,29,102 viral degradation or 
destroying the infectivity of the virus.102  Therefore, APCs and their function in the 
pathogenesis of PCV2 infection could be two-fold: 1) the virus is able to persist within these 
cells evading the immune system, and 2) APCs disseminate the virus throughout the body 
during subsequent cell trafficking. 
    Alveolar macrophages experimentally infected with PCV2 have reduced 
phagocytosis and microbicidal capability as demonstrated by a failure to destroy Candida 
albicans which further supports that PCV2 is immunosuppressive.14  The altered 
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microbicidal ability of alveolar macrophages creates a favorable environment within the cell 
for PCV2 survival and subsequent infection of other tissues as previously discussed.  In 
addition, PCV2-infected alveolar macrophages appear to have altered cytokine responses 
which include elevated levels of tumor necrosis factor-α (TNF) and interleukin (IL)-8.  
Increased levels of mRNA of alveolar macrophage derived neutrophil chemotactic factor-II, 
granulocyte colony-stimulating factor; monocyte chemotactic protein-1 and IL-8 were also 
observed.14   
 Pigs that were naturally infected with PCV2 and developed clinical disease had 
modified cytokine responses compared to PCV2-infected pigs that remained healthy.17  PCR 
was used to measure the level of gene expression of various cytokines in bronchial and 
inguinal lymph nodes.  Increased levels of IL-1β and IL-8 were detected as well as decreased 
levels of IL-4, IL-12, and interferon-γ (IFN-γ) in lymph nodes.  Interestingly, an 
overexpression of IL-10 was observed in the thymus.  The authors concluded the elevated 
levels of IL-10 was contributing to thymic depletion and atrophy in PMWS pigs and had a 
direct impact on T-cell development or regulation.  In addition, key cytokines responsible for 
driving specific immune polarization showed changes in their transcriptional phase in 
different tissues of diseased pigs resulting in a direct inhibition of T-cell responses. 
 Increased levels of circulating monocytes in PCV2-infected pigs have also been 
reported and appear to coincide with the histiocytic and/or granulomatous inflammatory 
responses noted in lymphoid tissue.11,17,91  An absolute or relative neutropenia in caesarian-
derived, colostrum deprived (CDCD) 11 or conventional pigs91 has been reported in 
experimental PCV2 infections.  Interestingly, a neutrophilia has been reported in naturally-
occurring PMWS-affected pigs and has not been reported in experimental infection.17,91  
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Segales et al. (2001) detected a population of cells using flow cytometry that appear 
consistent with granulocytic cells.  These cells were of lower density than normal 
granulocytes and appeared to correspond to immature cells such as band neutrophils 
indicating a neutrophilic response in PMWS-affected pigs. It is important to note that 
leukocyte values in these studies may be misleading as naturally-infected pigs have been 
exposed to additional pathogens which may influence the immune response not reflected in 
singularly infected pigs. 
 The neutrophil to lymphocyte abnormalities reported in pigs with PMWS can 
subsequently alter the neutrophil to lymphocyte (N/Y) ratio.17,91  Normal ratios of neutrophils 
to lymphocytes are reported to be in the vicinity of 0.4 to 0.6.  Pigs naturally infected with 
PMWS typically have an inverted ratio that ranged between 1.3 to 3.7,17,91 although, as stated 
earlier, this may potentially be influenced by secondary infections. 
 The immunological status of pigs at the time of exposure or their ability to develop 
adequate levels of protective immunity to PCV2 can influence the progression and clinical 
outcome of PMWS or severe PCVAD.  Conventional or CDCD pigs experimentally 
inoculated with PCV2 typically develop antibodies between 14 and 28 days post infection 
(dpi).1,4,10,11,59,76  Gnotobiotic pigs appear to seroconvert within a similar time frame as 
conventional or CDCD pigs.  One study utilizing PCV2-infected gnotobiotic pigs detected 
antibodies at 15 dpi using immunoperoxidase monolayer assay (IPMA).59  One group of pigs 
in the same study was administered twice a day cyclosporine A, orally, to suppress the 
immune response.  The treated pigs demonstrated a delayed antibody response compared to 
non-cyclosporine-treated pigs and did not seroconvert until 21 dpi.   
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 Additional studies investigating the immune response to PCV2 infection detected 
either a delay in the onset of protective immunity or an absence of PCV2 antibody in pigs 
that went on to develop PMWS.  Bolin et al. (2001) reported a detectable immune response 
in clinically normal CDCD pigs at 19 dpi inoculated with a virus isolated from a field 
outbreak of PMWS.11  The antibody levels increased steadily for the next 3 weeks.  
Interestingly, 4 of 15 pigs that became clinically affected within the group did not develop 
any detectable antibodies prior to euthanasia at 20-24 dpi.  In another study, clinically 
affected PCV2-infected CDCD pigs did not develop detectable antibody until 28 dpi 
compared to 14 dpi in subclinical and contact pigs used in the study.64 Therefore, it appears 
that PCV2-infected pigs with clinical disease either have a delayed antibody response or 
perhaps lack a total antibody response altogether.  This further suggests that an 
immunosuppressive feature is associated with clinical PCVAD.  
 PCV2 infected pigs that suppress viral replication, presumably through the 
development of an immune response, possess lower PCV2 serum antibody levels, less severe 
microscopic lesions and are less likely to develop clinical PCVAD compared to pigs that do 
not have detectable antibody levels.  Okuda et al. (2003) reported significant differences in 
the quantity and distribution of PCV2 antigen in tissues and antibody levels in infected 
CDCD pigs that developed PCVAD compared to pigs that remained clinically normal.  Pigs 
that developed PCVAD had higher levels of PCV2 in serum and a wider distribution of virus 
in tissues, but had lower antibody titers than their infected, clinically normal cohorts.  A 
different study examined the antibody response in SPF pigs receiving immunostimulation 
through injections of keyhole limpet hemocyanin in incomplete freund’s adjuvant 
(KLH/ICFA) compared to pigs administered a placebo.50  Four of the 10 infected pigs that 
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became clinically ill and died during the experiment had low antibody titers against PCV2 
detected by IPMA.  Ironically, one clinically affected pig was unable to develop anti-PCV2 
antibodies in spite of injections of KLH/ICFA.  Conversely, pigs that did not develop clinical 
disease had significantly higher antibody responses.   
 Gnotobiotic pigs have been used to investigate the adaptive immune response to 
PCV2 and its ability to reduce viral replication in tissue.59  In one study, twelve gnotobiotic 
pigs were infected with PCV2.  Four of the 12 inoculated pigs were given cyclosporine A to 
suppress the immune system.  All 4 PCV2-infected cyclosporine-treated pigs had higher 
PCV2 titers detected in tissue homogenates when compared to PCV2-infected pigs that did 
not receive cyclosporine.59  These results suggest that the adaptive immune response appears 
to be an important mechanism to control PCV2 replication. 
 Determining the total antibody response and seroconversion to a pathogen is one 
method of evaluating an immune response to an infectious disease but it is generally accepted 
that neutralizing antibodies more accurately reflect the ability of the host immune system to 
impede a viral infection.  Therefore, preventing the development of PCVAD may be more 
accurately reflected by the quantity of neutralizing antibodies produced on an individual 
basis.  In one study, 8 PCV2-infected gnotobiotic pigs were evaluated for neutralizing 
antibody response to infection.59  Three different PCV2 replication patterns were observed in 
these pigs.   In two pigs with the highest neutralizing antibody titers starting 15 dpi, no virus 
was detected; in a second group of five pigs with low neutralizing antibody titers, PCV2 
titers were detected at low to moderate levels at 15 dpi. The quantity of PCV2 in these pigs 
remained constant or decreased towards 21 dpi.  In a single pig with the highest level of 
PCV2, no neutralizing antibodies were detected.59  An additional study conducted in PCV2-
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infected specific pathogen free (SPF) pigs found neutralizing antibody titers were either 
absent or detected at low levels in PMWS-affected animals compared to clinically normal, 
unaffected pigs which had high levels of neutralizing antibodies.  In addition, the authors 
evaluated the evolution of the isotype response to PCV2 infection.  Interestingly, healthy pigs 
had IgM antibodies that persisted for 21 days, the duration of the trial, whereas PMWS-
affected pigs had IgM levels that rapidly decreased or remained at low levels.58  Additional 
antibody isotypes measured in the study included: IgG1, IgG2 and IgA.  These isotypes were 
present at only slightly lower levels in PMWS-affected pigs compared to clinically normal 
pigs.58  Fort et al.(2007) detected lower levels of neutralizing antibodies in naturally infected, 
PCVAD-affected pigs and determined this was inversely correlated with PCV2 titers in 
serum.  Experimentally infected pigs gave similar results demonstrating an increase in 
neutralizing antibody levels that corresponded to a decrease in viral load detected in serum 
by PCR.64 
 In summary, it appears that delayed or decreased PCV2-neutralizing antibody 
responses are correlated with an increased incidence of clinical PCVAD.  Therefore, an 
impaired humoral immune response appears to be more common in PMWS-affected pigs 
compared to pigs that develop an adequate immune response.26  Variation in the adaptive 
immune response between individual pigs may provide an explanation regarding why pigs 
are either severely affected by PCV2 or develop a subclinical infection and remain clinically 
normal. 
Lymphocyte Subsets 
 Leukograms from conventional,91 SPF,62 or CDCD11 pigs experimentally infected 
with PCV2 demonstrate a lymphopenia compared to sham-inoculated pigs.  In addition, 
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immunohistochemical staining for lymphocytes in the superficial inguinal lymph nodes 
showed reduced to almost absent numbers of B and T cells in PCVAD pigs.86  Lymphopenia 
has also been reported in pigs naturally-infected with PCV217,88,91 although studies are 
lacking in gnotobiotic pigs.  Evidence exists that pigs exhibiting clinical signs consistent with 
PMWS have a more prominent lymphopenia compared to clinically normal PCV2-infected 
pigs.62 
 Recent studies have focused on the subsets of lymphocytes that are depleted in 
PCV2-infected pigs.  Two studies evaluated the lymphocyte populations in peripheral blood 
mononuclear cells (PBMCs) of pigs naturally-infected with PCV2 and reported a relative 
decrease in the lymphocyte subsets,18,88 whereas monocytes were increased.88  Darwich et al. 
(2002) investigated the changes in the proportion of IgM+ cells in PCV2-infected and 
clinically wasted pigs and identified two clusters.  Pigs with less than 5% IgM+ cells in the 
total PBMC sample had significantly higher levels of virus in the tissues detected by in situ 
hybridization and more severe lesions than pigs with greater than 5% of PBMCs consisting 
of IgM+ cells.  The authors suggested this had a potential to be a good candidate marker for 
progression of PCV2 infection to PCVAD.18 
 Similar results have been reported when comparing quantities of total B lymphocyte 
populations and the severity of lesions in PMWS-affected pigs.86  Alteration of lymphocyte 
populations appears to occur rapidly in PCV2-infected pigs.  Nielson et al.(2003) detected a 
decrease in CD21+ B lymphocytes within 7 dpi progressing to a maximum depletion at 21 
dpi with early changes involving more B-cells than T-cell subsets although both B and T-
cells are similarly affected by PCV2 replication.104,105 
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 T-cell subsets in the peripheral blood and lymphoid tissues have also been 
investigated for changes secondary to PCV2 infection.  Initial studies of pigs naturally-
infected with PCV2 indicated a selective loss of the CD4+ subset of T-cells whereas CD8+ 
cells remained normal when both parameters were compared to healthy animals.88  Sarli et al. 
(2001) also reported a loss of CD4+ T lymphocytes in superficial inguinal lymph nodes that 
had been collected from pigs from field cases exhibiting PMWS.  Subsequent studies and in-
depth analysis of lymphocyte subsets have had conflicting results.  Depletion of CD4+ T cells 
was detected in poor doing pigs exhibiting wasting independent of their PCV2 status.  In 
contrast, CD8+ and CD4+CD8+ double positive (DP) T cells were depleted only in clinically 
wasted pigs that were infected with PCV2.18  These results suggest that both cytotoxic and 
memory lymphoid responses could be altered by PCV2.  Another study found that all T cell 
subsets are altered by PCV2 using flow cytometry and triple labeling.62  Characterization of 
CD3+CD4+CD8+ double positive (DP) T cells appeared to be more depleted than other 
subsets.  However, all T lymphocyte subsets, including CD3+CD4+CD8-, CD3+CD4-CD8+ 
(cytotoxic T cells), and CD3+CD4-CD8- (γδ T cells) were susceptible to PCV2-induced 
lymphopenia.62  Interestingly, CD3-CD4-CD8+ natural killer (NK) cells were also depleted in 
this study. 
 In summary, PCV2 infection induces a severe lymphopenia, primarily occurring in 
pigs that develop clinical PCVAD.  In addition, studies have shown that NK cells can be 
equally depleted enhancing the diminished immune response generated by infection with 
PCV2.  An early depletion of both B lymphocytes and all T lymphocyte sub-populations 
appears to play an important role in the pathogenesis of the disease.  However, some pigs are 
unaffected by PCV2’s immunomodulatory effect and retain the ability to develop an antibody 
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response that appears to be protective.  Understanding differences between pigs regarding 
susceptibility to the virus and its effect on the immune system requires further investigation.   
 Although lymphoid depletion is the hallmark feature of PCV2 infection and is the 
likely cause of decreased circulating lymphocytes, early reports did not associate PCV2 
infection and  viral replication within this subset of leukocytes.29  In contrast, Grierson et al. 
(2007) reported an initial upregulation of B and T cells during the early stages of PCV2 
infection.  These results were from naturally infected pigs which subsequently developed 
PCVAD.  It was hypothesized by the author that lymphocytes which have been upregulated 
during early stages of infection are more permissive to PCV2 replication and maybe a 
necessary component in the development of PCVAD.32  However, the timing and cause of 
the upregulated lymphocytes could be influenced by several factors, including secondary 
bacterial infections.  Therefore, it is difficult to conclude whether lymphocytes require prior 
stimulation in the pathogenesis of PCVAD based on this study.  There is now conclusive 
evidence that PBMCs stimulated with concanavalin A support higher levels of PCV2 
replication than unstimulated cells.105  In addition, it was demonstrated that stimulated T 
lymphocytes had significantly higher levels of viral DNA than stimulated 
monocyte/macrophages.  Therefore, PCV2 replicates in lymphocytes, particularly T 
lymphocytes, following stimulation.105  Ultimately, immunosuppression of the adaptive 
immune system appears to play a critical role in the development of PCVAD.   
Coinfections and Immune Stimulation 
 It has been difficult to experimentally reproduce clinical PCVAD similar to what is 
observed in pigs naturally infected with PCV2.  The presence of viral antigen in the absence 
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of any type of clinical disease has been difficult to explain in many experimental models 
including CDCD, colostrum-deprived snatch-farrowed, and conventional pigs.6,23,97 
 Gnotobiotic (GN) pigs provide an ideal model to study the direct effect of bacterial 
and/or viral infections on disease progression.  The terms GN and germ-free have been used 
interchangeably which is technically incorrect.  Germ-free pigs remain pathogen-free during 
their life whereas GN pigs are initially germ-free until they are inoculated with a known 
pathogen during experimental infection.  The pig, when derived by caesarian section and 
placed into a sterile environment, is immunologically naïve.  The epithelio-chorial placenta 
of pigs is structurally and physiologically incapable of allowing transfer of maternal antibody 
or other maternally derived macromolecules to the pig.40  GN pigs are also devoid of 
commensal or pathogenic gut microflora which can influence the development of adaptive 
immune responses.100  Although this model has been criticized for a lack of relevance to 
conventionally raised pigs, it provides an unbiased view of the pathogenesis associated with a 
single infectious agent.  In addition, germ-free pigs are useful when conventional pigs 
lacking maternal antibody are difficult to locate and in the investigation of newly discovered 
infectious agents. 
 Germ-free pigs were initially used as a method to repopulate SPF herds.  These pigs 
were caesarian-derived and colostrum-deprived and raised in sanitary conditions lacking 
microbiologically controlled environments.  Haelterman first described these methods in 
1956.33  Sterile pentub isolators are typically utilized for raising germ-free pigs in 
experimental settings.  The isolators are 4 feet by 2 feet, surmounted by polyvinyl canopies 
and house 4 pigs for the duration of the experiment.  Thus, germ-free pig studies have limited 
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space resulting in shorter experimental time due to size constraints.  The expense of 
operating a germ-free laboratory is another disadvantage in the use of this model. 
 Experimental reproduction of PMWS lesions and clinical signs was first reported by 
Ellis et al. (1999) in gnotobiotic pigs.  Pigs were inoculated with cell culture propagated virus 
harvested from lymph nodes from pigs with naturally acquired PMWS.  Clinically affected 
pigs developed lymphadenopathy, hepatitis, nephritis, interstitial pneumonia, myocarditis and 
gastritis.  One pig became depressed and was euthanized at 35 dpi.  The original intent of the 
study was to elucidate the pathogenicity of a novel PCV2 isolate, but retrospectively, porcine 
parvovirus (PPV) was found in the pigs and the inoculum.  The discovery that coinfection 
with PCV2 and PPV in pigs exhibiting clinical PMWS suggested that both agents could be 
involved in the induction of disease and co-factors may be required for developing PMWS.   
Experimental coinfection of pigs with PCV2 and other viral or bacterial agents has 
resulted in enhanced PCV2 replication67,72 and increase in severity of PCV2-associated 
lesions.4,39,43  Coinfection models that have been reported with PCV2-associated disease 
include PRRSV, SIV, M. hyopneumoniae, and other bacterial infections as well as the use of 
pathogens less commonly designated as primary pig pathogens.15,74  A case-control study 
using pigs with a clinical history of PCVAD and control pigs with no evidence of PCVAD 
found that among all viruses tested, coinfection with PRRSV created the highest risk for 
clinical PCVAD.75  Krakowka et al. (2000) reproduced PMWS in gnotobiotic pigs dually 
infected with PCV2 and PPV.  This study reinforced the apparent necessity requiring an 
additional cofactor or infectious agent with PCV2, to manifest clinical expression of the 
disease.49  Subsequent experimental models were developed using coinfection of the PCV2 
infected pigs with PRRSV or M. hyopneumoniae in an effort to understand the role additional 
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pathogens played in PCVAD, although most studies did not use gnotobiotic pigs.6,39,43,49,72  In 
each trial, lesions associated with PMWS were more severe when pigs were inoculated with 
PCV2 in addition to an additional pathogen compared to lesions observed in pigs infected 
with PCV2 alone.   
 Clinical disease consistent with PMWS has been induced using immunostimulation in 
experimentally infected, gnotobiotic pigs 48  Pigs were injected with KLH/ICFA 2 days post 
PCV2 inoculation.  All 7 of the inoculated pigs developed clinical PMWS by 35 dpi.  
Lymphoid depletion, severe hepatic necrosis and granulomatous lymphadenitis were detected 
in KLH/ICFA inoculated pigs infected with PCV2.  These lesions were similar to those 
observed in pigs coinfected with PCV2 and PPV.24,49  Lymph nodes draining KLH/ICFA 
injection sites consistently produced more infectious virus than contralateral lymph nodes 
receiving no regional immunostimulation.  Thus, PCV2 was established as the cause of 
PMWS when present with a cofactor initiating an immune stimulatory event.48   
 The results of this study raised concerns regarding the use of adjuvanted vaccines and 
their effect on the development of PMWS.  Research suggested that vaccination in 
conjunction with PCV2 infection may induce clinical PMWS depending on the type of 
vaccine adjuvant and the timing  of vaccine administration, although results have not been 
conclusive.73,78  Krakowka et al. (2005) induced PMWS in 5 of 12 gnotobiotic pigs 
inoculated with PCV2 and an M. hyopneumoniae bacterin containing mineral oil adjuvant, 
while none of the pigs given either a plant oil-based or alum-based adjuvant developed 
PMWS.  However, a recent report focused on the timing of vaccination and its effect on 
PCV2 replication and lesion severity.  Although the study confirmed differences in PCV2-
associated lesions among the treatment groups, there were either no or minimal PCV2-
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associated lesions when pigs were vaccinated 2 to 4 weeks prior to expected PCV2 
exposure.68  Therefore, in addition to the type of vaccine used, timing of injection and the age 
of the pig at the time of PCV2 infection may have an influence on the development of 
PCVAD. 
 Experimental immune stimulation has not consistently induced PMWS.  One study 
reported severe PMWS in 3 of 5 PCV2 inoculated pigs that received no immune co-
stimulation.50  In contrast, only 1 of 5 pigs receiving both PCV2 and KLH/ICFA became 
severely affected.  Pigs receiving no immune co-stimulation demonstrated clinical signs and 
microscopic lesions similar to the single clinically affected pig in the KLH/ICFA group.  It is 
important to emphasize that this experiment was conducted in conventional pigs as opposed 
to GN pigs.  It may be that the unique physiology and immune status of the GN pig would 
provide different results than the conventional pigs used in other experimental models.  
Although PMWS has been reproduced without immune co-stimulation,11,51 the results of 
most of the research to date suggests that immune stimulation is an important triggering 
factor for the development of clinical PCVAD. 
Diagnostics 
 Infection with and presence of the PCV2 virus is more common than PCVAD 
including PMWS.  Therefore, infection with or detection of the virus in tissue is not 
equivalent to clinical disease nor an indicator that disease will occur.  PCV2 antigen has been 
identified in field samples of grow/finish pigs as well as neonates that appear healthy and 
clinically normal.  Colostrum-deprived pigs experimentally infected with PCV2 had viral 
antigen in a number of tissues including the thymus, spleen, liver, lung and mesenteric lymph 
node, in the absence of clinical signs of PMWS throughout the trial.6  Since PCV2 is 
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ubiquitous in the swine population and infection does not necessarily correlate with clinical 
disease, a case definition for PMWS has been proposed.94  Diagnosis of PCVAD requires 
three criteria: 1) clinical signs characterized by wasting or failure to thrive, with or without 
respiratory disease; 2) histologic lesions typical of PCV2 infection characterized by 
lymphoid depletion and/or lymphohistiocytic to granulomatous inflammation in affected 
tissues; and 3) the presence of PCV2 antigen or nucleic acids in histologic lesions 
demonstrated by immunohistochemistry (IHC) or in situ hybridization (ISH).   
 Several diagnostic tests are currently available to confirm the presence of PCV2 
although careful interpretation is required.  PCVAD can only be diagnosed when PCV2 
antigen or DNA is demonstrated with the criteria listed above, independent of the 
demonstration of PCV2 antibody.71  Detection of PCV2 antigen in tissue by IHC or ISH are 
considered the gold standard and are routinely used in the diagnosis of PCVAD in many 
diagnostic laboratories.71,94 
 Serologic tests are available to detect the presence of antibodies to PCV2.  Current 
assays available include IPMA, indirect fluorescent antibody (IFA), enzyme-linked 
immunosorbent assay (ELISA) and serum neutralization (SN) assays.  The IFA and IPMA 
tests are subjective in nature and results have been shown to vary when the two methods 
were compared.55  In general, VN tests are difficult to perform as PCV2 lacks a cytopathic 
effect, thus requiring that the cells are stained using either fluorescent antibody or 
immunoperoxidase to demonstrate the presence of virus infection in cells.  Interpretation of 
the results requires skill as there are a number of factors that can potentially influence the 
sensitivity of the test such as background staining or background fluorescence, cross-reactive 
antibodies and cell cultures lacking adequate permissiveness to allow consistent viral 
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infection.  Results have been reported as a percent reduction in virus presence to determine 
titers, which have then been correlated to a reduction in the incidence of clinical disease 
attributed to PCV2 infection.26,58 
 Several PCR assays have been used to detect the presence of virus in serum and/or 
tissues including the use of multiplex PCR42,44,75 and real time PCR assays.104  The results of 
quantitative PCR have recently been used to predict the clinical outcome of PCV2-infected 
pigs.12,47  PCR values greater than 107 genomic copies/milliliter (ml) of serum appear to be 
correlated with the development of PCVAD and a subsequent poor prognosis for survival.  
Pigs with 106 genomic copies/ml are considered suspect for developing PCVAD, whereas 
pigs with less than 106 copies/ml are considered a low risk for developing clinical signs of 
disease in spite of PCV2 infection.47,71  Positive results for PCV2 by PCR alone do not 
establish a diagnosis of PCVAD.  Therefore, it is recommended that real-time PCR assays 
are used due to their high sensitivity and the ability to correlate results with clinical disease 
and microscopic evaluation of tissues before any clinical assessment is determined.   
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Abstract 
 In late 2005, a postweaning, high mortality syndrome spread rapidly through 
fattening barns in swine dense areas of the United States. Diagnostic investigations 
consistently isolated porcine circovirus type 2 (PCV2) from diseased tissues. Subsequent 
genetic analysis revealed that the infectious agent was a PCV2 variant termed “PCV2b”. 
Prior to late 2004, only PCV2a, but not PCV2b, had been reported in North America. In this 
communication, we reproduce severe postweaning multisystemic wasting syndrome 
(PMWS) in germ-free pigs using infectious PCV2a and PCV2b generated from DNA clones 
constructed from field isolates identified in the 2005 outbreak. Clinical signs exhibited by 
diseased pigs included anorexia, dyspnea and listlessness. Mortality was typically observed 
within 12 hours of onset of dyspnea. The most striking microscopic lesions in affected 
animals were severe hepatic necrosis and depletion of germinal centers in lymph nodes with 
associated abundant PCV2 viral antigen. Clinical signs and lesions observed in these studies 
were comparable to those reported in experiments with germ-free pigs inoculated with a 
PCV2a isolate while concurrently receiving immune-stimulation or co-infection with porcine 
parvovirus. The animals in these studies were confirmed to be free of detectable porcine 
parvovirus, bovine viral diarrhea virus, porcine reproductive and respiratory syndrome virus, 
swine hepatitis E virus, and aerobic and anaerobic bacteria throughout the studies. Thus, in 
these studies, both PCV2a and PCV2b isolates were singularly capable of inducing high 
mortality in the absence of any recognized infectious co-factor.  
Keywords: PCV2; porcine circovirus associated disease; PCVAD; gnotobiotic pigs 
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Introduction 
 Porcine circovirus (PCV) is a member of the genus Circovirus of the Circoviridae 
family.27,38  This family consists of a diverse group of animal viruses that possess a small, 
closed circular, single-stranded DNA genome that replicates through double-stranded 
intermediates. Two genotypes of PCV have been identified.  PCV type 1 (PCV1) is non-
pathogenic, while PCV type 2 (PCV2) has been implicated as the etiological agent of a 
collection of disease syndromes labeled Porcine Circovirus Associated Disease (PCVAD) 
which include postweaning multisystemic wasting syndrome (PMWS) in swine. 2,12,14,17 
  PMWS was first recognized in western Canada in 1991 as a disease affecting young 
pigs (3- to 6-weeks of age) with a high morbidity rate but low mortality rate.12,16,18  Affected 
pigs became lethargic and exhibited clinical signs of wasting, weight loss, respiratory 
disease, or jaundice. PMWS was reported in Western Europe and Great Britain in the late 
1990s where it appeared as a much more severe disease that affected older pigs with 
increased mortality as compared to North America.2,26,42  Since then, PCV2 has been isolated 
from pigs throughout the world and PCVAD has become an economically important disease 
among swine producing countries.9 Recently, phylogenetic analyses showed that PCV2 can 
be further divided into PCV2 group 1 or PCV2b and PCV2 group 2 or PCV2a.11,32  
  In 2004, high mortality in 10- to 16-week-old swine in Eastern Canada was 
recognized in numerous herds.8,13  The affected pigs exhibited unthriftiness, anorexia, 
lethargy and severe dyspnea.  The syndrome spread rapidly through Canada and was first 
observed in the United States in mid 2005 in North Carolina and quickly spread throughout 
the United States within a year.3,19 Investigations into separate outbreaks in North Carolina, 
Kansas, Iowa,11 and Missouri (unpublished observations) found PCV2b present in 19 
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affected animals tested while PCV2a was present in only 2 of pigs tested. Prior to the 
emergence of this high-mortality syndrome in 2005, only PCV2a viruses were detected in the 
United States.11,32 Detection of large amounts of PCV2b in affected pigs, almost to the 
exclusion of PCV2a, suggested a correlation between the PCV2b virus and the onset of this 
high-mortality syndrome in finishing age swine.  Similar observations were made in 
Canada.15 
  Recently, we reported on the experimental infection of germ-free pigs with PCV2a 
and PCV2b derived from DNA clones.24  Following inoculation, 4 of 4 PCV2b and 1 of 4 
PCV2a germ-free pigs either died or had to be euthanized due to severe clinical disease.  
No other infectious agents were identified in all pigs suggesting the mortality was solely 
attributable to PCV2 infection.   In this communication, we report on a germ-free pig study 
expanding this original observation.    
Material and Methods 
Virus and cell culture 
PCV2a or PCV2b virions were recovered from the same pig in 2005 from an outbreak 
of severe PMWS in North Carolina.11 The sequenced viral genomes were deposited in 
GenBank (accession numbers DQ629115 and DQ629114 for PCV2b and PCV2a, 
respectively).  Each viral genome was inserted into the EcoR1 restriction enzyme site of a 
Bluescript plasmid (Strategene, La Jolla, CA).  After the PCV2 genome was excised from the 
Bluescript plasmid and circularized by ligation, the ligated DNA mixture was transfected into 
PK15 cells which had been seeded at approximately 60-80% confluency as previously 
described.10  The ligated DNA mixture was replaced with fresh minimal essential medium 
(Earle’s salts and L-glutamine) with 10% fetal bovine serum after 5 hours.  After 1 week, the 
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transfected cultures were frozen and thawed 3 times to prepare viral stocks.  Both inocula 
were passed through a 0.45 micron filter and the  titer of each virus stock was determined 
using fresh PK15 monolayer cells and immunohistochemistry (IHC) staining as previously 
described10 with each foci of stained cell(s) reported as an IHC unit.  The number of genomic 
copies of the challenge viruses was determined using a real-time PCR assay as previously 
described35 with the following modifications.  Briefly, DNA was extracted from virus stock 
using a commercial DNA isolation kit (QIAmp® DNA Blood Mini Kit, Qiagen, Valencia, 
California). The PCR master mix consisted of 2 µl DNA extract, 12.5 µl of the commercially 
available master mix (TaqMan Universal PCR Master Mix, PE Applied Biosystems), 1 µl of 
400 nM each of 5’-primer and 3’-primer, and 0.5 µl of 200 nM probe.   Each sample was run 
in duplicates with a PCV2 isolate used as a positive control and a PCV2-free negative control 
on each plate.  Values were reported as genomic copies per ml of inoculum.  Each plate was 
run utilizing the following protocol: 2 minutes at 50 C, 10 minutes at 95 C, followed by 40 
cycles of 15 seconds at 95  C and 1 minute at 60 C.   
Gnotobiotic piglet husbandry  
  Isolator units used in the study were cleaned with sodium hypochlorite and water 
prior to sterilization with ethylene oxide prior to the start of the experiment. Piglets were 
derived from three crossbred sows free of PRRS virus by cesarean section and immediately 
placed in the sterile surgical isolator. Within 2 to 4 hours after surgery, piglets were 
transferred from the sterile surgical isolator into sterile pentub isolators (4 pigs / isolator).  
The isolators were of stainless steel construction surmounted with polyvinyl canopies and 
maintained under positive pressure.  The floor area was approximately 61 cm x 122 cm and 
divided into four compartments by removable stainless steel partitions.  Isolator units were 
 44 
maintained at an ambient temperature of 32º C using an exterior heat source.  The 
temperature was gradually decreased over the course of the experiment to a maintenance 
temperature of 27º C. Intake and exhaust air was HEPA-filtered. Pigs were fed a 
commercially-available pasteurized milk diet twice daily from shallow steel troughs for the 
duration of the experiment with increasing quantities to a maximum of 370 ml per feeding 
(Esbilac® Kansas City, KS USA).  
Experimental design  
  Two pig studies were conducted.  Experiment 1 was designed to test the 
pathogenicity of PCV2a and PCV2b viruses, and a brief summary of the clinical disease was 
previously reported.24  Experiment 2 was designed to evaluate potential effects of challenge 
dose on the pathogenicity of PCV2a and PCV2b. 
  Experiment 1:  Twelve pigs were randomly divided into 3 groups with 4 pigs per 
group/isolator. At 10 days-of-age (day 0 of the experiment) pigs in isolators 1 and 2 were 
given a 1 ml oronasal inoculation of PCV2a or PCV2b, respectively, each at a dilution of 3.8 
x 103 IHC units/ml (Table 1). Pigs in isolator 3 were sham-inoculated and received the same 
quantity of a PCV2-free cell culture medium. Pigs were monitored daily for clinical signs 
and euthanasia was scheduled for half of the pigs at 25 days-post-infection (dpi) and the 
remaining half at 35 dpi.  EDTA blood was collected at 7, 24, 29, and 35 dpi and tested for 
PCV2 by real-time PCR and for PCV2-specific-antibody by ELISA.  At necropsy, 
bronchoalveolar lavage fluid (BALF) was collected, and sections of lung, liver and assorted 
lymph nodes were collected for formalin fixation and fresh tissue storage at -80°C. 
  Experiment 2:  Twenty-eight pigs were used in the study.  The pigs were randomly 
divided into 7 groups with 4 pigs per group/isolator. At 7 days-of-age, a 1 ml volume of 
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PCV2b challenge virus was administered to the appropriate groups of pigs by the oronasal 
route; pigs in isolator 1 received undiluted stock virus (2b-H), pigs in isolator 2 received a 
100-fold dilution of the initial virus stock (2b-M) and pigs in isolator 3 were administered a 
10,000-fold dilution of stock virus (2b-L) (Table 1).  Similarly, pigs in isolators 4, 5, and 6 
were inoculated with 1 ml of undiluted (2a-H), a 100-fold dilution (2a-M), or a 10,000-fold 
dilution of PCV2a challenge stock virus (2a-L), respectively (Table 1).  Pigs in isolator 7 
were negative controls and received 1 ml of PCV2-free cell-culture medium.  One-half of the 
pigs in each group were scheduled for necropsy at 28 dpi and the remaining pigs were 
scheduled for necropsy at 41 dpi.  EDTA blood samples were collected at 14, 19, 22, 26, 29, 
33, 36, and 41 dpi to test for PCV2 DNA by real-time PCR and for PCV2-specific-antibody 
by ELISA.  At necropsy, BALF was collected, and sections of lung, liver and assorted lymph 
nodes were collected for formalin fixation. In addition, fresh tissues were collected and 
stored at -800 C. 
Lesion examination  
 Macroscopic lesions were evaluated and scored from (-) being normal and (+++) 
being most severely affected with diffuse dark red congestion and interlobular pulmonary 
edema.34,36 Microscopic lesions were examined and scored by a pathologist blinded to the 
treatment groups using a scoring system that has been previously described.34,36  
Immunohistochemical detection of PCV2-specific antigen was performed on formalin-fixed 
paraffin-embedded sections of lymphoid tissue, lymph nodes and livers of all pigs using a 
rabbit polyclonal PCV2 antiserum as previously described.43  
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Viral and bacterial detection assays  
A single, gel-based PCR assay was used to test all pig samples in both experiments 
for viruses capable of transplacental infection which included: porcine reproductive and 
respiratory syndrome virus (PRRSV),45 bovine viral diarrhea virus (BVDV),41 porcine 
parvovirus (PPV),44 and swine hepatitis E virus (HEV).20  At weekly intervals and at 
necropsy, rectal swabs were collected from all pigs and pooled together by isolator. The 
swabs were tested for aerobic and anaerobic bacteria using routine microbiologic methods.  
Briefly, 2 dacron swabs were used to swab the rectum of each pig, and the swabs were 
processed immediately after removal from the isolator.  One swab was placed in 
peptone/yeast/glucose (PYG) anaerobic media using the Hungate anaerobic system.21,40,46  
The second swab was used to test for aerobic bacteria and placed in Trypticase Soy Broth 
(Becton Dickinson, Sparks, MD) and streaked on a blood agar plate with 5 percent bovine 
blood, a MacConkey agar plate, and a Phenylethylalcohol agar plate.   All plates and media 
were incubated for 24 hours at 37°C and checked for growth.  After 24 hours, the media from 
the TBS tube was plated on blood agar plates and checked for growth at 24 and 48 hours post 
inoculation.  Any bacteria were identified using conventional microbiological techniques.  
Real time PCR was performed on weekly EDTA blood and necropsy serum samples 
using an Applied Biosystems 7500 real-time PCR system to verify PCV2 viremia and 
quantification of virus in experiment 1 and 2 as previously described in the virus and cell 
culture section of this manuscript.  Real time PCR was also performed on BALF samples in 
experiment 1 and 2 for quantification and comparison between dose groups.   
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Serology  
  All necropsy serum samples were tested for the presence of antibodies to select 
viruses.  A commercially available ELISA (HerdChek PRRS 2XR, Idexx Laboratories, Inc. 
Westbrook, Maine) was used to test for the presence of PRRSV antibodies. A 
hemagglutination inhibition test was used for PPV antibody.29  Viral neutralizing titers for 
BVDV were determined in a microtiter plate assay, using the cytopathic BVDV strains 296c 
(BVDV2 species) and TGAC (BVDV1 species) as reference strains as previously described.4  
Briefly, serial 2 fold dilutions of each experimental serum were diluted in complete cell 
culture medium containing 10% fetal calf serum, 25µg/ml gentocin and 1.4µM L-glutamine. 
A 100 µl aliquot of diluted serum and 50 µl of virus stock containing 1000 TCID50 /ml was 
added to each well and incubated for 1 hr at 37°C after which, a 100 µl aliquot of complete 
cell culture medium (10% fetal calf serum, 25µg/ml gentocin and 1.4µM L-glutamine) 
containing 20,000 bovine turbinate (BT) cells was added to each well. The plate was then 
incubated for 5 days and each well observed for any cytopathic effect. Each neutralization 
assay was done in replicates of five. Titers were calculated based on the observed reduction 
in cytopathic effect using the methods of Reed & Muench..39  An ELISA for PCV2 was 
performed using recombinant ORF2 capsid protein of PCV2 as previously described.31  
Samples were considered to be positive if the calculated sample-to-positive (S/P) ratio was 
0.2 or greater, and suspect with S/P ratios between 0.12 – 0.2.31   
Statistical analysis 
  To evaluate the effect of dose in Experiment 2, the macroscopic and microscopic 
lesion scores and log10 transformed PCV2 PCR genomic copies/ml were separately analyzed 
for each PCV2 isolate using analysis of variance (ANOVA) with a p-value less than 0.05 
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considered to be significant (JMP, SAS Institute, Cary, NC).  Response variables shown to be 
significantly different were subjected to pair-wise comparisons using the Tukey-Kramer test. 
Results 
PCV2 inocula   
PCV2a and PCV2b stock viruses were diluted to approximately equal titers based on 
IHC units for use in each experiment.  Back titrations and quantitative PCR results of each 
inoculum are reported in Table 1.  In experiment 1 the PCV2a and PCV2b virus titers were 
similar.  In experiment 2 the PCV2b undiluted virus was 8.5 x 103 IHC units/ml and 12.0 
log10 genomic copies/ml.  Titer of PCV2a undiluted virus was 8.3 x 104 IHC units/ml and 
13.1 log10 genomic copies/ml.  In experiment 1 and 2, PCV2 recovered from the serum of 
PCV2a and PCV2b challenged pigs in both experiments was sequenced and found to be 
identical to the respective challenge virus (data not shown).   
Clinical signs, macroscopic and microscopic lesions  
 All control pigs in both experiments were normal in appearance and behavior for the 
duration of each study. No macroscopic lesions were observed at necropsy. No microscopic 
lesions were found in any tissues examined.   
 Experiment 1: As previously reported,24 all four PCV2b inoculated pigs became 
clinically affected and either died or were euthanized between 22 and 27 dpi.  Only one of 
the four PCV2a inoculated pigs became clinically affected and was euthanized at 35 dpi. The 
remaining three PCV2a inoculated pigs were normal in appearance and behaviour throughout 
the experiment.  All clinically-affected PCV2a and PCV2b pigs exhibited clinical signs and 
had macroscopic lesions as previously reported (Table 2).24   
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 Experiment 2: Two 2b-H, three 2b-M, and one 2b-L pigs, and one 2a-H, three 2a-M, 
and one 2a-L pigs either died or were euthanized prior to scheduled necropsy times (Table 2). 
The remaining 13 pigs were normal in appearance at the scheduled necropsy time.   
All clinically-affected PCV2a and PCV2b pigs exhibited similar clinical signs. The 
first clinical signs observed were anorexia and listlessness that was frequently followed by 
dyspnea within a few hours. The dyspnea became severe and was followed by death within 
12 hours if the pigs were not euthanized. The most frequently observed macroscopic lesions 
in the PCV2a or PCV2b infected pigs that succumbed to infection consisted of pneumonia 
with interlobular edema (Fig 1 and Table 2), enlarged tracheobronchial lymph nodes, 
peritoneal and thoracic effusions that were cloudy and icteric, and gelatinous edema around 
the kidneys, base of the heart, and the mesentery of the spiral colon. Less frequently, 
hemorrhages were seen along the renal cortico-medullary junction and the liver was 
discolored. Microscopic lesions were found in a variety of tissues; the most significant 
lesions were interstitial pneumonia, a loss of distinct lymphoid follicles and depletion of 
lymphocytes in all lymph nodes examined (Fig. 2a), and severe vacuolar degeneration and 
necrosis of hepatocytes with multifocal areas of hemorrhage (Fig. 2b). Abundant PCV2 
antigen was observed in tissues of the affected pigs (Figures 2a and 2b).   
Some PCV2a and PCV2b infected pigs were normal in appearance at necropsy, but 
had similar macroscopic lesions, although less severe, when compared to clinically-affected 
pigs.  These subclinical pigs had macroscopic lesions consisting of pulmonary interlobular 
edema and enlarged lymph nodes and most of them had microscropic lesions consisting of 
various degrees of lymphoid depletion and granulomatous inflammation in one or more 
tissues.   
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Bacterial and viral analysis  
No aerobic or anaerobic bacteria were isolated from the rectal swabs collected from 
any of the pigs in either experiment.  In addition, all samples collected from control pigs in 
both experiments tested negative for PCV2 by real-time PCR (data not shown).  All control 
pigs tested negative for PPV, PRRSV, swine HEV, and BVDV nucleic acid.   
  Experiment 1: Based on the quantitative PCR assay, all PCV2a- and PCV2b-
inoculated pigs developed PCV2 viremia post challenge (Table 3).  At 7 dpi all PCV2a 
infected pigs and 2 of the 4 PCV2b infected pigs were viremic with PCV2 genomic copies 
ranging from 2.5 to 4.5 log10/ml of plasma.  At the time of necropsy, all PCV2a- and PCV2b-
inoculated pigs were viremic and the titer of PCV2 genomic copies ranged from 5.6 to 10.7 
log10/ml of plasma.  Virus titers in the BALF fluid from all infected pigs in both genogroups 
at necropsy ranged from 8.1 to12.2 log10 genomic copies/ml (Table 4).  All PCV2a and 
PCV2b pigs tested negative for PPV, PRRSV, swine HEV and BVDV nucleic acid.   
  Experiment 2: PCV2 PCR data are summarized in Table 3.  At 14 dpi, all 2b-M and 
2b-H pigs were viremic with genomic copies ranging from 5.9 to 8.8 log10/ml of plasma.  
PCV2 DNA was not detected in any of the 2b-L pigs until 19 dpi.  At necropsy, all PCV2b 
pigs were viremic with titers ranging from 5.6 to 10.5 log10 genomic copies/ml of plasma.  
All PCV2a pigs were viremic at 14 dpi with genomic copies ranging from 3.3 to 8.7 log10/ml 
of plasma.  At necropsy, titers ranged from 5.7 to 12.6 log10 genomic copies/ml of plasma.  
The viral titers in BALF of infected pigs at necropsy ranged from 7.0 to12.6 log10 genomic 
copies/ml (Table 4).   
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Serology 
 All samples collected from control and experiment 1 pigs tested negative for PCV2 
antibodies by ELISA (data not shown).  In addition, all pigs tested negative for PPV, 
PRRSV, and BVDV antibodies.   
Experiment 2: At the time of euthanasia 6 of the 13 subclinical pigs with no clinical 
signs had developed antibody to PCV2; one 2b-H pig was seropositive by 26 dpi and one 2b-
M pig was seropositive by 41 dpi. One 2b-L pig had suspect levels of antibodies by 41 dpi. 
Two of the 2a-H pigs were seropositive by 26 dpi and one 2a-H pig seroconverted by 28 dpi, 
and one 2a-L pig became seropositive at 41 dpi (Table 4).  
  With the exception of 3 pigs, all PCV2a and PCV2b inoculated pigs were free of 
detectable PPV, BVDV and PRRSV antibodies.  The 3 pigs had neutralizing antibody 
activity against BVDV type 2, but not BVDV type 1. The antibody titers were 1:8, 1:16, and 
1:32 in the sera collected at necropsy.  All 3 pigs were littermates and exhibited clinical 
disease at 4 to 5 weeks of age (24 to 28 DPI) with moderate to severe lesions at necropsy. 
Two of them were in the 2b-M group and one in the 2b-L group. None of the other pigs had 
BVDV neutralizing activity at any point in the trial. 
Discussion 
 In the studies reported here, experiment 1 established the ability of PCV2a and PCV2b to 
induce clinical disease, characteristic lesions and mortality consistent with PCV2 in germ-free pigs.  
All 4 pigs that received the PCV2b challenge virus either died or were euthanized prior to the 
scheduled necropsy times of 25 and 35 dpi. Only one PCV2a pig demonstrated clinical signs on 35 
dpi, which was the scheduled necropsy date for that pig, and the last day of Experiment 1.  Although 
2 pigs necropsied at 24 dpi had relatively low virus levels when compared to the pig with clinical 
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disease, it is unknown if those pigs would have developed clinical disease if they would have lived 
longer.  Likewise, it is not known if the unaffected pig was in the process of clearing the infection 
since the pig had a relatively low virus load at 35 dpi, or if it would have eventually succumbed to 
the virus.  This is an inherent problem in germ-free pig experiments in which the duration of the 
study is limited by the size of the pigs and the capacity of the isolator.  However, based on the results 
from Experiment 2, it appears that some pigs may not develop clinical disease and may initiate a 
protective immune response against the virus by 41dpi.  Conventional, specific pathogen free and 
CDCD pigs experimentally infected with PCV2 typically seroconvert between 14 and 21 dpi.5,28,37  
In Experiment 2, the first serum antibodies were detected in one pig at 22 dpi, and 6 of the remaining 
12 pigs that survived to the scheduled necropsy times, seroconverted between 26 and 41 dpi.  
Compared to conventional pigs, it appears that germ-free pigs are slower to develop a humoral 
response to PCV2. In addition, it could be questioned as to whether some pigs will develop an 
antibody response at all. 
 Experiment 2 used 100-fold virus dilutions to evaluate a dose-dependent clinical effect of 
PCV2a and PCV2b in germ-free pigs.  The dilutions were selected with the anticipation of 
demonstrating clinical differences; thus the highest dose of inoculum (undiluted stock) was 
administered.  Other groups received 100 or10,000 fold dilutions of the virus stock solution.  Back 
titration of the challenge viruses indicated there was approximately a 10 fold difference in the viral 
titer of the undiluted stock of PCV2a and PCV2b challenge viruses based on IHC assays that was 
confirmed by quantitative PCR (Table 1).  Although the quantitative PCR assay used may provide an 
accurate count of genomic copies, it does not give insight into the number of infectious units in the 
challenge dose.  Moreover, the cell culture was not washed following the transfection step resulting 
in a virus preparation that contains not only nascent virus, but may include excess DNA from the 
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transfection process.  Although the 2b-L challenge dose per pig contained less than one cell culture 
infectious unit (about 0.85 IHC units), it is clear the challenge inoculum contained at least one pig 
infectious dose (PID) since the pigs did become infected.  How many PID of virus were in the 2b-L 
inoculum is not known, but we can presume the 2b-H dose contained at least 10,000 times as many 
PID.  Assuming all pigs are equally susceptible to 2a challenge virus, the 2a-H inoculum contained 
at least 100,000 PID/ml.  The relationship between a PID unit and an IHC unit is unknown due to the 
low sensitivity of the IHC assay for quantitative purposes.  A major factor contributing to low 
sensitivity is the relatively low percentage of PK-15 cells used in the IHC assay that are permissive 
for PCV2 growth.  Perhaps a recently described PK-15 cell line that has been selectively cloned for 
enhanced PCV2 replication would increase the sensitivity of the IHC assay.47 
Based on serum virus load observed during the early stages of infection there were 
significant differences between the low-dose and medium- and high-dose groups for each virus.  
This apparent difference was not recognized during the later stages of infection.  However, there was 
a trend for such a response based on the onset of clinical disease and virus load in plasma.  During 
the early stages of infection, the onset of clinical disease occurred at 21dpi in the PCV2a and PCV2b 
high and medium dose groups that had larger quantities of virus detected in plasma compared to the 
onset of clinical disease in the 2a-L and 2b-L groups which occurred later at 34 and 37 dpi, 
respectively.  Likewise, 4 of the 6 pigs that seroconverted by necropsy time were in the high dose 
challenge group.  Although there may be dose-dependent trends based on the onset of clinical 
disease, the character of the disease was similar among all clinically affected pigs within each 
treatment group.  Since the PCV2a and PCV2b groups received different doses of challenge virus, a 
direct comparison of the pathogenicity of the PCV2a and PCV2b is not possible.  However, since the 
severity of clinical disease in the latter stages of the experiment was similar between the two groups, 
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it appears that there were minimal differences between the viruses, specifically the nature of the 
lesions, level of virus replication and mortality, under the conditions of this study. 
 It has been proposed that the potential for PCV2 to cause disease can be predicted by the 
quantity of detectable virus in serum or tissue by quantitative PCR.  Conventional pigs with serum 
values greater than 107 genomic copies per milliliter appear more likely to experience severe 
PCVAD/PMWS compared to pigs with virus levels of 105 genomic copies or less.6,33  Interestingly, 
a similar relationship was observed in both experiments reported here as animals that were clinically 
affected tended  to have higher virus levels in serum than pigs that appeared clinically normal at the 
time of necropsy.  Moreover, when the clinically normal pigs (13 pigs) were separated into two 
groups based on PCV2 seroconversion, the subclinical pigs with PCV2 ELISA antibodies (6/13) had 
significantly less serum PCV2 DNA levels at 36 and 41dpi.  A similar trend was found in the PCV2 
DNA levels in BALF at necropsy.   
 In the studies reported here, the virus levels in germ-free pigs are considerably greater than 
what has been reported in conventional pigs experimentally-infected with PCV2.35  Some of this 
difference may be attributed to different assays and methodologies; however, we believe most of the 
differences are due to the unique physiology and immune status of the germ-free pig.  In the case of 
PCV2 infection, it is clear that germ-free pigs exacerbate clinical signs that might be seen in like-
infected conventional pigs, thus we anticipate that the virus load would be higher in germ-free pigs 
as well.  
Neutralizing antibody activity against BVDV type 2 was detected in the necropsy sera of 3 
pigs from experiment 2. We believe the neutralizing antibody activity is non-specific as the titers for 
the 3 pigs were relatively low and no other pigs in either study developed antibody to the virus 
including littermates.  In addition, PCR assays for BVDV were negative for all pigs in each study 
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and each affected pig had pleural effusion indicating significant inflammation which has been shown 
to induce non-specific antibody responses in bodily fluids.25  Pigs which developed neutralizing 
antibodies to BVDV were located in the 2b-M and 2b-L virus groups which had received inoculum 
diluted 100-fold or 10,000-fold.  In contrast, pigs in the 2b-H group did not have neutralizing 
antibodies; however, these pigs received undiluted virus which would have contained the highest 
amount of BVDV if the inoculum had been contaminated.  Previous studies have demonstrated 
passive transfer of BVDV and bovine parvovirus antibodies in bovine milk products fed to neonatal 
piglets.30  Although unlikely, pigs may have absorbed BVDV antibodies during the initial feeding of 
bovine milk products (Esbilac) resulting in weak neutralizing activity by the time of necropsy. 
  Under these experimental conditions, severe disease and death was caused by 
experimental inoculation of germ-free pigs with PCV2a and PCV2b isolates derived from a 
2005 U.S. case of the high mortality disease syndrome in finishing swine.  Our observations 
are in contrast to previous germ-free pig studies in which little, if any, clinical disease was 
observed following infection with only a PCV2a isolate.23 However, germ-free pigs 
inoculated with PCV2a and coinfected with PPV,1 or with immune stimulation by keyhole 
limpet hemocyanin in incomplete Freund’s adjuvant22 had clinical signs and mortality similar 
to what was observed in this study. Those earlier studies led to the hypothesis that clinical 
disease following PCV2 infection is dependent on a co-factor; e.g. a viral infection or 
immunostimulation.22 In the present study we did not detect any infectious agents other than 
PCV2 challenge viruses in the inoculated pigs. The pigs did not receive any apparent 
immunostimulating event, and were maintained in sterile isolators for the duration of each 
experiment. Since the viruses used in this study were derived from cloned PCV2a and 
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PCV2b DNA, we presume the clinical effects were attributed to the rescued viruses used in 
the experiments and not extraneous viruses.  
 It is possible that some aspect of the routine husbandry required for raising germ-free pigs 
provides an immunostimulating event, and thus the necessary co-factor to induce clinical disease. 
However, based on previous germ-free pig experiments, no significant up-regulation of the immune 
system has been observed in the absence of colonizing bacteria or PRRSV infection.7  Since the 
hypothesis for the induction of disease is based on synergism between PCV2 and a cofactor, no 
clinical event would be detected in the absence of PCV2 infection. In addition, the milk diet 
prepared from cow’s milk has been formulated for small mammals and might be considered 
immunostimulatory to the pig, thus providing a cofactor for the PCV2-infected pig.  We believe this 
possibility is unlikely based on a lack of any evidence of immunostimulation in previous germ-free 
pig experiments and our unpublished observations.   
 Results from experiment 1 and 2 demonstrate the PCV2b virus is pathogenic in a germ-free 
pig model.  Collectively, the germ-free-pig lesions mimic what has been reported in North American 
field cases following the onset of the high mortality syndrome in 2004/2005.  This observation 
supports the role of PCV2 in this disease.  However, this experimental work does not explain why 
the introduction of an apparently new PCV2 genogroup (PCV2b) to North America appears to have 
spread through high-density pig areas like an emerging infectious agent.11,15  Likewise, it is not clear 
why some of our experimentally-infected pigs died and some appeared unaffected by the same virus 
challenge.  Additional studies are necessary to investigate these issues and determine if these two 
viruses are representative of PCV2a and PCV2b viruses circulating in the pig populations.   
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Table 1: Quantity of virus inoculum used in each of 2 experiments  
based on immunohistochemistry units/ml and real-time PCR genomic copies/ml 
 
 
Experiment 
 
PCV2 Dose Group 
 
IHC units/ml 
 
PCR PCV2 copies/ml a 
 
1 
 
 
2 
 
Gp 1 
Gp 2 
 
Gp1-H 
 
3.8 x 103  
3.8 x 103 
 
8.5 x 103 
 
--- 
--- 
 
12.0b 
 Gp1-M --- 10.0 
 Gp1-L --- 8.1 
 
2 
 
Gp2-H 
 
8.3 x 104 
 
13.1 
 Gp2-M --- 11.2 
 Gp2-L --- 9.2 
    
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comparing IHC units/ml and PCR copies/ml of virus inoculum used in Experiment 1 & 2. 
Immunohistochemistry values correspond to a back titration after inoculation.  --- =  not tested.  
a = log base 10 values.  b = values include virus and plasmid quantification. 
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Table 2.  Macroscopic and Microscopic Lesions in selected tissue - scores are based on severity of lesions
Clinically Necropsy Interlobular Thoracic
Experiment 1 Pig No. affected dpi Pneumonia Liver Kidney Spleen TB LN Pul Edema Effusion
PCV2a 46A No 24 - / ++ - / ++ - / + - / ++ ++ / + - -
PCV2a 46B Yes 35 + / +++ - / +++ + / + - / +++ ++ / ++ + +
PCV2a 46C No 24 - / +++ - / ++ - / - - / + +++ / ++ - -
PCV2a 46D No 35 - / ++ - / ++ - / + - / + ++ / ++ - -
PCV2b 47A Yes 23* + / +++ - / +++ - / - - / ++ ++ / +++ + +
PCV2b 47B Yes 26* + / ++++ - / +++ - / + - / +++ ++ / +++ + +
PCV2b 47C Yes 27* + / ++++ + / +++ - / - - / +++  + / +++ + +
PCV2b 47D Yes 23* + / ++ - / ++ - / - - / ++  + / +++ + +
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lungs, liver, kidney, spleen, and tracheobronchial lymph node (TBLN) were evaluated at necropsy.  Macroscopic lesions 
represented by the numerator, and microscopic lesions represented by the denominator.  Lungs evaluated for interstitial 
pneumonia; liver, kidney and spleen evaluated for inflammation and TBLN evaluated for degree of lymphoid depletion.  Lesion 
score ranges from (-) = normal to (+++) = severe. Presence of pulmonary edema and pleural effusion used an identical scale.  
Necropsy dpi column indicates scheduled necropsy times unless indicated by an asterisk  
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Table 2. contd   Macroscopic and Microscopic Lesions in selected tissue - scores are based on severity of lesions
Clinically Necropsy Interlobular Thoracic
Experiment 2 Pig No. affected dpi Pneumonia Liver Kidney Spleen TB LN Pul Edema Effusion
PCV2a-H 55A No 28 - / + - / ++ - / - - / ++ +++ / ++ - / - -
PCV2a-H 55B No 41 - / + - / + - / - - / - + / ++ - / - -
PCV2a-H 55C Yes 26* + / ++ - / +++ - / - - / +++ ++ / +++ + / + -
PCV2a-H 55D No 41 - / - - / + - / + - / - - / + - / - -
PCV2a-M 56A Yes 26* + / +++ - / +++ - / - - / +++ +++ / +++ + / ++ +
PCV2a-M 56B No 41 - / - - / + - / ++ - / ++ +++ / ++ - / - -
PCV2a-M 56C Yes 25* + / ++ - / + - / - - / +++ +++ / ++ + / +++ +
PCV2a-M 56D Yes 37* + / + + / +++ - / - - / +++ +++ / +++ + / ++ -
PCV2a-L 54A No 28 - / - - / ++ - / - - / - +++ / ++ - / - -
PCV2a-L 54B No 41 - / + - / ++ - / + - / ++ +++ / ++ - / - -
PCV2a-L 54C No 28 - / ++ - / - - / - - / +++ +++ / +++ - / - -
PCV2a-L 54D Yes 34* + / + + / +++ + / - - / ++ + / ++  -/ + -
PCV2b-H 51A Yes 25* - / ++ - / + - / - - / +++  + / +++ + / + +
PCV2b-H 51B No 28 - / + - / ++ - / ++ - / +++ +++ / ++  -/ + -
PCV2b-H 51C No 41 - / - - / + - / - - / - + / ++ - / - -
PCV2b-H 51D Yes 29* - / - - / + - / - - / +++ - / NA + / - -
PCV2b-M 52A No 41 - / - - / + - / - - / - - / - - / - -
PCV2b-M a 52B Yes 24* + / + - / + - / - - / +++ +++ / +++ + / +++ +
PCV2b-M a 52C Yes 25* + / ++ - / ++ - / - - / +++ ++ / +++ + / +++ +
PCV2b-M 52D Yes 21* + / ++ - / ++ - / - - / +++ +++ / +++ + / +++ +
PCV2b-L a 53A No 28 + / ++ - / + - / - - / ++ +++ / +++ + / + -
PCV2b-L 53B Yes 37* + / + - / + - / - - / +++ +++ / +++ + / ++ -
PCV2b-L 53C No 28 + / + - / ++ - / + - / ++ +++ / +++ - / - -
PCV2b-L 53D No 41 + / ++ - / + - / - - / +++ +++ / + + / ++ -
 
 
 
 
 
 
 
Lungs, liver, kidney, spleen, and tracheobronchial lymph node (TBLN) were evaluated at necropsy.  Macroscopic lesions represented 
by the numerator, and microscopic lesions represented by the denominator.  Lungs evaluated for interstitial pneumonia; liver, kidney 
and spleen evaluated for inflammation and TBLN evaluated for degree of lymphoid depletion.  Lesion score ranges from (-) = normal 
to (+++) = severe. Presence of pulmonary edema and pleural effusion used an identical scale.  Necropsy dpi column indicates 
scheduled necropsy times unless indicated by an asterisk (*).   a = pigs with nonspecific activity for BVDV antibody.  N/A = not 
available 
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Table 3. PCV2 Quantitative Real-Time PCR and Serology at Necropsy - Genomic Copies/ml Log10 Values
Clinically Necropsy Necropsy
Experiment 1 affected Pig No. 7 dpi 24 dpi 29 dpi 35 dpi dpi  Serology
PCV2a No 46A 2.5 c 7.9 - - 24 Neg
PCV2a No 46B 4.5 8.5 9.7 9.4 35* Neg
PCV2a Yes 46C 2.8 7.1 - - 24 Neg
PCV2a No 46D 4.5 5.9 5.8 5.6 35 Neg
PCV2b Yes 47A 4.4 - - - 23* Neg
PCV2b Yes 47B Neg b 9.0 - - 26* Neg
PCV2b Yes 47C Neg b 8.9 - - 27* Neg
PCV2b Yes 47D 2.9 - - - 23* Neg
PCV2 genomic copies per ml of serum measured by quantitative real-time PCR.  Absent values indicate 
recent euthanasia due to clinical disease or scheduled necropsy.  Necropsy dpi column indicates scheduled 
necropsy times unless indicated by an asterisk (*).  All values for 0 dpi were below the limits of detection.  a 
= pigs with non-specific antibody to BVDV.  b = below the limits of detection.  c = values in the table have 
been converted to log base ten.   
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Table 3. contd    PCV2 Quantitative Real-Time PCR and Serology at Necropsy - Genomic Copies/ml Log10 Values
Clinically Necropsy Necropsy
Experiment 2 Pig No. affected 14 dpi 19 dpi 22 dpi 26 dpi 29 dpi 33 dpi 36 dpi 41 dpi dpi  Serology
PCV2a-H 55A No 6.6 c 8.3 8.3 7.3 - - - - 28 POS
PCV2a-H 55B No 6.6 7.8 7.3 7.2 6.0 7.1 6.5 5.7 41 POS
PCV2a-H 55C Yes 8.7 10.5 11.2 11.6 - - - - 26* Neg
PCV2a-H 55D No 6.7 8.4 8.2 8.0 7.4 6.9 7.2 6.4 41 POS
PCV2a-M 56A Yes 6.9 10.6 10.7 11.1 - - - - 26* Neg
PCV2a-M 56B No 6.4 8.3 8.3 8.1 8.5 7.7 7.8 7.5 41 Neg
PCV2a-M 56C Yes 7.6 9.8 9.5 - - - - - 25* Neg
PCV2a-M 56D Yes 5.9 10.2 10.7 11.4 11.7 11.4 12.3 - 37* Neg
PCV2a-L 54A No 5.6 7.8 7.7 7.3 - - - - 28 Neg
PCV2a-L 54B No 4.6 7.4 8.6 8.9 8.6 8.0 7.9 7.0 41 POS
PCV2a-L 54C No 6.1 8.6 9.8 8.8 - - - - 28 Neg
PCV2a-L 54D Yes 3.3 8.2 9.0 10.4 11.2 12.9 - - 34* Neg
PCV2b-H 51A Yes 7.6 10.3 10.5 - - - - - 25* Neg
PCV2b-H 51B No 6.6 8.2 8.2 7.8 - - - - 28 Neg
PCV2b-H 51C No 6.0 7.5 7.4 6.9 6.4 5.8 6.4 5.6 41 POS
PCV2b-H 51D Yes 8.8 10.3 10.0 10.2 10.6 - - - 29* Neg
PCV2b-M 52A No 5.9 7.7 7.5 6.8 7.1 5.9 6.0 5.6 41 POS
PCV2b-M a 52B Yes 7.4 9.0 10.4 - - - - - 24* Neg
PCV2b-M a 52C Yes 6.7 8.3 10.5 - - - - - 25* Neg
PCV2b-M 52D Yes 7.3 9.3 - - - - - - 21* Neg
PCV2b-L a 53A No Neg b 5.7 8.6 9.4 - - - - 28 Neg
PCV2b-L 53B Yes Neg b 7.5 9.0 9.8 9.6 10.3 10.3 - 37* Neg
PCV2b-L 53C No Neg b 6.4 8.1 8.0 - - - - 28 Neg
PCV2b-L 53D No Neg b 4.7 4.9 7.1 8.2 8.7 9.2 9.1 41 SUS
 
PCV2 genomic copies per ml of serum measured by quantitative real-time PCR.  Absent values indicate recent euthanasia due to 
clinical disease or scheduled necropsy.  Necropsy dpi column indicates scheduled necropsy times unless indicated by an asterisk 
(*).  All values for 0 dpi were below the limits of detection.  a = pigs with non-specific antibody to BVDV.  b = below the limits of 
detection.  c = values in the table have been converted to log base ten.   
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Table 4. Quantitative PCV2 PCR values of necropsy samples.
Genomic copies/ml in Log10 values.
Clinically Serum PCR BAL PCR
Experiment 1 Pig No. Affected Necropsy Necropsy
PCV2a 46A No 7.9 c 9.6 c
PCV2a 46B Yes 9.4 12.2
PCV2a 46C No 7.1 8.6
PCV2a 46D No 5.6 8.1
PCV2b 47A Yes 9.4 10.8
PCV2b 47B Yes 10.7 11.6
PCV2b 47C Yes 9.2 10.7
PCV2b 47D Yes 8.8 10.5
 
 Comparison of quantitative PCR values for necropsy samples 
from Experiment 1 & 2.  a = pigs with non-specific antibody to 
BVDV. c = values in the table have been converted to log base ten.  
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Table 4.contd   Quantitative PCV2 PCR values at necropsy.
Genomic copies/ml in Log10 values.
Clinically Serum PCR BAL PCR
Experiment 2 Pig No. Affected Necropsy Necropsy
PCV2a-H 55A No 6.8 c 7.8 c
PCV2a-H 55B No 5.7 7.4
PCV2a-H 55C Yes 11.9 11.3
PCV2a-H 55D No 6.4 7.9
PCV2a-M 56A Yes 11.1 10.0
PCV2a-M 56B No 7.5 8.0
PCV2a-M 56C Yes 9.8 9.0
PCV2a-M 56D Yes 11.9 11.4
PCV2a-L 54A No 6.4 8.5
PCV2a-L 54B No 7.0 8.6
PCV2a-L 54C No 8.2 9.9
PCV2a-L 54D Yes 12.6 12.6
PCV2b-H 51A Yes 11.0 10.2
PCV2b-H 51B No 7.3 8.9
PCV2b-H 51C No 5.6 7.0
PCV2b-H 51D Yes 10.5 11.6
PCV2b-M 52A No 5.6 7.4
PCV2b-M a 52B Yes 10.1 10.7
PCV2b-M a 52C Yes 10.5 11.7
PCV2b-M 52D Yes 9.1 10.2
PCV2b-L a 53A No 9.8 9.5
PCV2b-L 53B Yes 10.2 11.1
PCV2b-L 53C No 7.6 9.5
PCV2b-L 53D No 9.1 10.1
Comparison of quantitative PCR values for necropsy 
samples from Experiment 1 & 2.  a = pigs with non-specific 
antibody to BVDV. c = values in the table have been converted to 
log base ten.  
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Figure legends 
Fig. 1. Lung and liver lesions from experiment 2. Lungs from pigs inoculated with either 
PCV2a or PCV2b. The diseased lungs are diffusely mottled-tan and had well-demarcated, 
dark red tan areas of consolidation with interlobular edema.  Livers from piglets inoculated 
with either PCV2a or PCV2b virus. Tissues were either stained with hematoxylin and eosin 
(H&E) or immunohistochemistry (IHC) for viral antigen as specified.  
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Figure 1. 
 
Lung – Gross Lesions 
21 Days Post Infection   26 Days Post infection 
 
 
Lung Histopathology Lesions – 25 Days Post Infection 
H&E – Lung edema    IHC 
 
 
Liver Histopathology Lesions - 34 Days Post Infection 
H&E      IHC 
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Abstract 
Porcine circovirus type 2 (PCV2) is a single-stranded circular DNA virus that is the 
causative agent of porcine circovirus associated disease (PCVAD), a disease complex 
affecting swine around the world.  Although this virus is believed to negatively affect the 
host’s immune system, the mechanism by which PCV2 induces disease is not completely 
understood. This report describes a series of PCV2 experiments using the germ-free pig 
model in which a correlation was noted between abnormal leukograms and development of 
clinical disease in PCV2-infected pigs.  The leukogram was characterized by a lymphopenia 
beginning within 14 days post inoculation (dpi) followed by an absolute neutrophilia 
approximately one week later. No significant changes in the circulating monocyte, basophil, 
and eosinophil cell populations were detected.  The combination of an absolute neutrophilia 
and lymphopenia produced a neutrophil/lymphocyte ratio that was predictive of clinical 
disease and was inversely correlated with the presence of neutralizing antibodies. Based on 
previous reports, the lymphopenia may be attributed to a direct cytolytic effect of the virus 
and could negatively affect the pig’s immune response. The role of the neutrophilia in the 
pathogenesis of PCVAD in germ-free pigs is not known. 
Keywords: PCV2; porcine circovirus associated disease; PCVAD; leukogram; germ-free pigs 
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Introduction 
Porcine circovirus type 2 (PCV2) is the causative agent of post-weaning-
multisystemic-wasting-syndrome (PMWS), a swine disease first observed in Canada in 
1991.5  It is characterized by general wasting, respiratory disease, jaundice and pallor in 
young pigs resulting in production losses and variable mortality.  Since the discovery of 
PCV2 in 1996, this virus has been linked to other disease syndromes (porcine dermatitis and 
nephropathy syndrome30, reproductive failure35, and enteritis14) that are collectively known 
as porcine circovirus associated disease (PCVAD).  PCV2 is ubiquitous in swine herds 
around the world and most herds are endemically infected with PCV2. The majority of pigs 
remain clinically unaffected whereas a low percentage can display severe clinical disease. 
Studies investigating this enigma have focused on the host immune response and 
pathogenesis of the disease.                            
Animal studies can be confounded since most conventionally-farrowed pigs have 
passively acquired PCV2 immunity. The main strategies to obtain PCV2-negative pigs for 
research purposes include segregated early weaning27 and the derivation of cesarean-derived, 
colostrum-deprived (CDCD) or germ-free pigs. Success of the different strategies to obtain 
PCV2-negative pigs is dependent on absence of congenital infection, early horizontal 
transmission and prevention of environmental contamination by using isolation facilities or 
sterile isolators for germ-free pigs. Each practice has advantages and disadvantages which 
need to be considered when interpreting experimental results.  
Numerous reports describing experimental PCV2 inoculation have been published 
since 1997; however, only a limited number have focused on the acute and chronic host 
response in controlled experiments.  Typically, single infection with PCV2 produces a 
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subclinical infection.1,2,28 This is in contrast to concurrent infection of PCV2 with other 
pathogens1,7,16, or additional immune stimulation treatment.15  Both have been shown to 
exacerbate PCV2 infection through modulation of the pig’s immune system via an unknown 
mechanism. 
The development of PCVAD has been linked to an absent or delayed adaptive 
immune response.  The quantity and distribution of PCV2 in tissues,24 as well as clinical 
disease,3,11,17,31 have been inversely correlated with the magnitude of the antibody response. 
At the cellular level, lymphopenia is a consistent feature of pigs that develop severe 
PCVAD3,23,32 and PCV2 is thought to have a direct role.36,37  Monocytosis and neutropenia 
have been reported following experimental PCV2 infection3,32 and PCV2 antigen can be 
demonstrated in the cytoplasm of monocytes, pulmonary macrophages and monocyte-derived 
macrophages.10  A neutrophilia has been reported in pigs with naturally occurring PCVAD6,32 
however, this was not a feature under controlled experimental conditions using CDCD or 
conventional pigs.3,32  To our knowledge, a correlation between leukogram and clinical 
disease have not been examined in gnotobiotic pigs.  
PCV2-infected gnotobiotic pigs have been monitored for adaptive immune response 
variations related to the level of virus replication in tissue.21  PCV2 was not isolated from the 
inguinal lymph nodes of gnotobiotic pigs with high levels of neutralizing antibodies in their 
serum.  In contrast, a gnotobiotic pig lacking PCV2 neutralizing antibodies had high 
quantities of PCV2 in lymph node homogenate.  Similar results have been reported in 
clinically-affected PCV2-inoculated specific pathogen free (SPF) pigs with low levels of 
PCV2 antibodies when compared to clinically normal pigs.17  The importance of the adaptive 
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immune response in controlling PCV2 is supported by a correlation between the absence of 
neutralizing antibodies and high levels of virus replication in PMWS affected swine.20     
The immune system in germ-free pigs is not fully activated; however, this animal 
model allows studying the direct effect of PCV2 on the pig without the possible influence of 
passively acquired maternal immunity, environmental factors, and known and/or unknown 
viral and bacterial co-infections.  Here we report a direct relationship between an abnormal 
leukogram and the onset of clinical disease in a germ-free pig model.  These findings are 
based on data from successive studies using cell culture propagated PCV2 isolates or isolates 
derived from infectious DNA clones.4 
Materials and Methods 
Animals and experimental design 
 Germ-free piglets were derived aseptically from crossbred sows by cesarean section as 
previously described.9  All pigs in all experiments were treated in a similar fashion.  Piglets 
were housed in sterile, stainless-steel pentub isolators (4 pigs / isolator) and fed a 
commercially-available pasteurized milk diet.  Pigs were identified with a two digit number 
followed by a letter.  The first number represents the experiment, the second number 
represents the isolator, and the letter corresponds to the individual pig.  Each pig within an 
isolator received the same treatment, either PCV2 or a sham inoculation at about 7-10 days of 
age.  Two of the four pigs in each isolator were pre-selected for euthanasia and necropsy 
around 21-29 or 35-46 days-post-inoculation (dpi) unless they were severely affected at 
which time they were euthanized prior to scheduled necropsy times.  Experiments 1, 2, and 3 
utilized cell culture propagated PCV2a (isolate 688) and experiments 4 and 5 utilized PCV2a 
(isolate NC1) and PCV2b (isolate NC2) derived from DNA clones.  For PCV2 inoculation, 
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each pig was restrained and received a 1 ml volume of sham or virus solution split between 
each nostril. Blood samples and rectal swabs were collected at selected times and passed out 
of the isolator in a sterile fashion.  Rectal swabs were cultured for bacteria as previously 
described.9  Bronchoalveolar lavage fluid (BALF) was collected at necropsy, and sera and 
BALF were tested for the presence of PCV2 via a gel-based PCR assay (Experiments 1, 2, 
and 3) or by a quantitative PCR assay (Experiments 4 and 5) as previously described.22,26  
  Experiment 1:  Two 7-day-old pigs were oronasally exposed to PCV2a isolate 688 
(1.0 x 104 IHC units in a 1 ml volume) with a scheduled necropsy at 42 dpi (Table 1).   
  Experiment 2:  Four 10-day-old pigs were oronasally exposed to PCV2a isolate 688 
(1.0 x 104 IHC units in a 1 ml volume), and four 10-day-old pigs were oronasally exposed to 
a sham inoculum.  Necropsy was scheduled for half of the pigs at 11 and 25 dpi, respectively 
(Table 1).   
  Experiment 3:  Fourteen pigs were divided into 4 treatment groups.  All pigs received 
an intraperitoneal injection of 3 mgs fluorescyl-keyhole limpet hemocyanin (FL-KLH) at 9 
days of age.  Isolator 33 pigs (n = 4) were exposed to a sham inoculum at 9 days of age.  
Isolator 34 pigs (n = 4) were exposed oronasally to PCV2a isolate 688 (1.0 x 104 IHC units in 
a 1 ml volume) at 9 days of age.  Isolator 35 (n = 2) pigs were colonized with E. coli 68 at 3 
days of age, and received a sham inoculum at 9 days of age.  Isolator 36 pigs (n = 4) were 
colonized with E. coli at 3 days of age, and received PCV2a isolate 688 (1.0 x 104 IHC units 
in a 1 ml volume) at 9 days of age.  Half of the pigs in each group were scheduled for 
necropsy 32 dpi and at 46 dpi, respectively (Table 1). 
  Experiment 4:  Twelve pigs were divided into 3 treatment groups.  At 7 days-of-age 
PCV2-inoculated pigs received an oronasal inoculation of 3.8 x 103 IHC units per ml of 
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virus.  Isolator 46 pigs received a 1 ml volume of PCV2a (NC1), isolator 47 pigs received 1 
ml of PCV2b (NC2), and isolator 45 pigs received a sham challenge of cell culture lysate.  
EDTA treated blood samples were collected at 7, 24, 29, and at necropsy at 35 dpi (Table 1).  
The lesions, virus load, and antibody levels found in this pig experiment have been reported 
previously.9    
  Experiment 5:  Twenty-eight pigs were divided into 7 treatment groups.  At 7 days-
of-age, a 1 ml volume of three different doses of PCV2a challenge virus were given to pigs 
by the oronasal route;  4 pigs in isolator 55 received undiluted stock virus, 4 pigs in isolator 
56 a 100-fold dilution and 4 pigs in isolator 54 a 10,000-fold dilution of stock virus.  
Similarly, 4 pigs in each of isolators 51, 52, and 53 were inoculated with 1 ml of undiluted, a 
100-fold dilution, or a 10,000-fold dilution of PCV2b challenge stock virus, respectively.  
Four pigs in isolator 57, the negative control isolator, received 1 ml of cell-culture medium 
only.  One-half of the pigs were scheduled for necropsy at 29 dpi and the other half at 41 dpi.  
Blood samples were collected in EDTA tubes at 14, 19, 22, 26, 29, 33, 36, and 41 (Table 1). 
The lesions, virus load, and ELISA serology found in this pig experiment have been reported 
previously.9     
 Virus Inocula 
  The PCV2a-688 strain used in experiments 1, 2, and 3 was isolated during the late 
1990s from a PMWS case in Manitoba, Canada3.  The virus was propagated and titrated in a 
PCV2-free PK15 cell culture.  An aliquot of stock virus was diluted to about 10,000 
CCID50/ml for use as challenge virus.  The PCV2 challenge viruses for experiments 4 and 5 
were generated from DNA clones derived from field samples submitted to NADC in 2005 
from North Carolina, USA.4   
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 Clinical Evaluation 
  All pigs were monitored daily for clinical signs, and at necropsy they were evaluated 
for macroscopic lesions in lungs.  At the time of necropsy, PCV2 infected pigs were 
classified as clinical (clinically affected - anorexic, lethargic, dyspneic, and/or with 
macroscopic lung lesions) or subclinical (no clinical signs and no macroscopic lung lesions).   
 Viral Detection Assays 
  PCV2 DNA was detected by PCV2 –specific gel-based (Experiments 1-3)22 or real-
time PCR (Experiment 4 and 5)26 as previously described.  In addition, at necropsy time pigs 
were classified as infected or not-infected based on detection of PCV2 nucleic acid in serum 
and BALF.   
 Leukogram 
  Blood samples were collected at selected times in all experiments and analyzed for 
white blood cells (WBC) using a multispecies hematology instrument (Hemavet HV950FS, 
Drew Scientific, Inc., 2003). The WBC count was reported as actual number of neutrophils, 
lymphocytes, monocytes, basophils, eosinophils, and total WBC per microliter of whole 
blood. Leukogram values for control pigs from experiments 2, 4, and 5 were utilized to 
establish normal values for germ-free pigs.  The mean and standard deviation was calculated 
to establish a normal range for comparative purposes with any values greater than 2 standard 
deviations from the mean of the control pigs considered as an abnormal value.  Control pigs 
from experiment 3 were not used to derive normal values because isolator 33 became 
contaminated with bacteria and isolator 35 was colonized with E. coli.  The leukogram 
parameters of the PCV2-infected pigs were reported as being normal or abnormal relative to 
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the control leukogram.  In addition to WBC, a ratio was determined between the total 
neutrophil count and total lymphocyte count reported as the N/L ratio.   
Virus neutralization test 
  Virus neutralization (VN) tests were conducted on necropsy serum samples from the 
28 experiment 5 pigs as previously described,8 with the following modifications:  Fifty 
microliters of serum taken at necropsy  were serially two-fold diluted in MEM with Earles 
(0.25% LAH with NaPyr with 5% fetal bovine serum, 2 µg/ml fungizone, 25,000 units 
penicillin/ml, 25,000 µcg streptomycin/ml, 25,000  µcg neomycin/ml and 250 units 
bacitracin/ml) in 96-well plates from 1:2 to 1:1024.  PCV2 virus stock was diluted to 4.0 x 
103 IHC units/ml in MEM w/Earles and 50 microliters of virus preparation was added to each 
well.  After incubation for 1 hour at 37o C, 4 x 104 freshly trypsinized porcine kidney cells 
were added to each well and incubated for 48 hours at 37o C in 5% CO2 atmosphere.  Each 
plate was washed twice with wash buffer [phosphate-buffered saline (PBS) (Mallinckrodt, 
Hazelwood, MO, USA) and 0.05% Tween 20 (Sigma Aldrich, St. Louis, MO, USA)] and 
fixed with 40% acetone (Mallinckrodt, Hazelwood, MO) and 0.02% bovine serum albumin 
(Sigma Aldrich, St. Louis, MO) in PBS for 10 minutes.  Each plate was incubated with 100 
µl of a polyclonal serum against PCV2 diluted 1:1000 in binding buffer (1000ml PBS, 29.5g 
NaCl and 0.1ml Tween 20) for 1 hour at room temperature.  Plates were washed 3 times with 
wash buffer and 100 µl of a 1:1000 diluted horse-radish-peroxidase labeled rec protein G 
(Invitrogen, Carlsbad, CA) is added for 30 minutes at room temperature.  Plates are washed 
again 3 times and 200µl of amino-ethyl-carbazole is added to each well, in the dark, for 20 
minutes or until the reaction is adequately revealed.  All samples were tested in duplicate 
with a serum sample of known neutralizing antibody titer included as a positive control.  
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Eight wells were used as negative controls which included 50µl of 4.0 x 103 IHC units/ml of 
virus inoculum, 50µl MEM and 4 x 104 PK15 cells per well.  Plates were read under an 
inverted microscope at 100X magnification.  Each IHC foci were counted as 1 virus particle.  
Neutralizing titers were reported as a 90% and 50% reduction in viral infectivity in cell 
culture as reported previously.8 
Statistical analysis 
  Leukogram values for control pigs (n=12) from experiments 2, 4, and 5 were utilized 
to establish normal values for germ-free pigs (Table 2).  The mean and standard deviation 
was calculated for the control pigs to establish a normal range for comparative purposes.  
PCV2-infected pigs with values greater than 2 standard deviations for neutrophils and N/L 
ratios or less than 2 standard deviations for lymphocytes from the mean of the control pigs 
were considered an abnormal value.  Differences among clinical-PCV2-infected, subclinical-
PCV2-infected, and subclinical-non-infected (control) pigs were analyzed for each 
experiment and for all experiments combined.  Neutrophil to lymphocyte (N/L) ratios and 
leukogram values were subjected to pair-wise comparisons using the Student’s t-test (JMP, 
SAS Institute, Cary, NC).     
Results 
Clinical Evaluation 
Once the disease process started, in each of the 5 experiments, the presentation of 
clinically-affected pigs was similar despite infection with different PCV2 strains.  Clinical 
presentation was also similar in experiment 3 in which pigs were infected with PCV2 in 
addition to colonization with E. coli or injection with FL-KLH.    
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Experiment 1:  Both pigs were normal in appearance and behavior until the morning 
of 25 dpi at which time pig 14A was moribund.  It was removed from the isolator and 
euthanized and necropsied in routine fashion.  Gross lesions consisted of pneumonia with 
interlobular edema, enlarged tracheobronchial lymph nodes, peritoneal and thoracic effusions 
that were cloudy and icteric, and gelatinous edema around the kidneys, base of the heart, and 
the mesentery of the spiral colon.  Hemorrhages were seen along the renal cortico-medullary 
junction and the liver was discolored.  The stomach was full of milk from the prior feeding, 
about 16 hours previously.  Pig 14D appeared normal at this time and had a vigorous 
appetite.  On the morning of 26 dpi, pig 14D was moribund similar to pig 14A the day 
before.  This pig was necropsied and had similar gross lesions, including a full stomach.  
Both pigs were considered clinically affected (Table 1).  
Experiment 2:  All pigs were necropsied at the scheduled times either 11 or 25 dpi.  
Each pig appeared clinically normal and no gross lesions were noted at necropsy (Table 1).   
Experiment 3:  All control pigs (33A, 33B, 33C, 33D) were necropsied on scheduled 
days and were normal in appearance and behavior.  PCV2-infected pigs 34B, 36B and 36C 
were clinically affected and euthanized on 32, 27 and 22 dpi, respectively (Table 1).  The 
remaining pigs in isolators 34 and 36 were considered to be subclinically affected.   
Experiment 4:  There were no significant differences in clinical signs, lesions and 
PCV2 genomic copy numbers at necropsy between the PCV2a- and PCV2b-infected groups.  
Five of 8 PCV2 inoculated pigs were clinically affected (Table 1).  All 4 pigs inoculated with 
PCV2b were euthanized between 23 to 27 dpi, and one PCV2a inoculated pig was clinically 
affected the morning of 35 dpi, its scheduled necropsy time. 
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Experiment 5:  There were no significant differences between clinical signs, 
mortality, or lesions at necropsy between PCV2a- and PCV2b-infected groups.  Fourteen of 
24 PCV2-infected pigs became clinically affected (Table 1).  Of the 14 clinically affected 
pigs, 7 pigs were inoculated with PCV2a and 7 pigs were inoculated with PCV2b.  Eleven of 
the 14 pigs became dyspneic and/or moribund and were euthanized between 21 and 37 dpi 
and 3 of the 14 pigs had lung lesions at scheduled necropsy times although clinical signs 
were not observed. 
 Virus and bacterial detection 
All pigs in each of the 5 experiments were negative for PCV2 DNA at 0 dpi.  All 
PCV2-inoculated pigs in each experiment were considered infected since PCV2 was detected 
in their sera and BALF at necropsy.  PCV2 DNA was not detected in any of the control pigs 
at necropsy time.   
No bacterial growth was detected in any of the pigs in experiments 1, 2, 4, and 5.  In 
experiment 3 at 0 dpi the control isolator 33 was found to be contaminated with 
Chryseomonas luteoal and remained so for the duration of the experiment.   
In experiments 4 and 5, there were no differences in PCV2 genomic copies detected 
in necropsy serum or BALF between the PCV2a and PCV2b infected pigs.  Since all PCV2 
infected pigs had similar clinical presentations and mortality rates, these groups will be 
considered as having had a similar treatment, i.e., oronasal exposure to PCV2, and will be 
discussed as a collective group.  Thus, all 18 control pigs were subclinical and not PCV2-
infected, and among the 46 PCV2 inoculated pigs, 24 were clinically abnormal and PCV2-
infected, and 22 were subclinical and PCV2-infected. 
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Leukogram 
Control pigs:  Normal leukogram values from control pigs in experiments 2, 4 and 5 
are listed in Table 2. Although control pigs in isolators 33 and 35 were subclinically 
colonized with bacteria, their individual leukogram values did not fall outside of the normal 
range established by the control pigs (2 standard deviations from the mean) (Table 2).  
However, when the control pigs from experiments 2, 4, and 5 were compared with the 
experiment 3 control pigs in the student’s t-test, the experiment 3 control pigs had a 
statistically significant increase in mean neutrophil count.  No other statistically significant 
differences were found between these groups.     
Subclinical PCV2-infected Pigs:  Seventeen of 22 PCV2-infected subclinically-
affected pigs had abnormal leukograms i.e. one or more cell populations, and/or the N/L ratio 
were outside the normal range (Table 3).  These values were characterized most often by an 
increased N/L ratio, followed by an absolute neutrophilia and lymphopenia.  Essentially all 
monocyte, basophil and eosinophil counts at necropsy time for subclinical, PCV2-infected 
pigs were within normal limits (data not shown) and no significant differences were found 
between the sub-clinically infected pigs and control leukogram values.   
Clinical PCV2-infected Pigs:  Abnormal leukograms were identified in 24 of 24 
PCV2-infected clinically-abnormal pigs (Table 3).  Monocyte, basophil and eosinophil 
counts at necropsy time for clinical, PCV2-infected pigs were within normal limits (data not 
shown).  Clinically-affected pigs had significant increases in neutrophils and N/L ratio, and a 
significant decrease in lymphocytes compared to the sub-clinical PCV2-infected pigs and the 
controls.   
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Virus Neutralization Test 
Virus neutralization tests were performed on necropsy sera collected from experiment 
5 (Table 4).  No virus neutralization activity was detected in the control pigs.  A 90% 
reduction (VNT90) in virus-infected cells was detected in 8 of 24 PCV2-infected pigs with 
reciprocal titers ranging from 2 to 128.  Virus neutralization tests detecting a 50% reduction 
(VNT50) in virus revealed an increase in titer for each of the 8 VNT90 positive pigs.  Two 
additional pigs, 51B and 53C, had a VNT50 of 8 and 4, respectively.   
When the 24 PCV2-infected pigs were divided by clinical status, 2 of the 14 clinically 
affected pigs had a detectable VNT at time of necropsy, pigs 53D and 54C.  They were 
euthanized 41 and 29 dpi, and had VNT90 titers of 16 and 2 and VNT50 titers of 128 and 8, 
respectively.  Eight of the 10 subclinical PCV2-infected pigs had VNT titers at time of 
necropsy.  Subclinical pigs 54A, and 56B did not develop detectable VNT antibody by the 
time of necropsy at 29 and 41 dpi, respectively.  Of the 24 PCV2-infected pigs, the 10 pigs 
that had a detectable VNT50 titer had a group mean N/L ratio of 1.05 (0.36-3.10) whereas the 
14 that did not had a group mean of 4.68 (0.66-12.96).  The N/L ratio representing the 14 
pigs lacking a VNT50 was significantly higher that the 10 pigs with a VNT50. 
Discussion 
As part of a routine procedure, the WBCs of pigs at necropsy time for experiments 1, 
2 and 3 were evaluated.  Ten of the 14 PCV2-infected pigs had abnormal leukogram values 
compared to controls, consisting primarily of neutrophilia and lymphopenia.  Upon further 
evaluation, clinically affected pigs demonstrated pronounced leukogram abnormalities and 
significantly elevated N/L ratios compared to both subclinical-infected and control pigs 
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(Table 3).  Based on these findings, we hypothesized that the abnormal N/L ratios were 
predictive of clinical disease, a hypothesis supported by the outcome of the experiments. 
The goal of experiments 1, 2, and 3 was to characterize the clinical response of germ-
free pigs inoculated with a well characterized PCV2 strain, 688.  It was anticipated the 
clinical response would mimic the findings of others in which germ-free pigs given PCV2 
alone replicated the challenge virus and remained clinically normal for the duration of the 
isolator experiment.7,16  In the previously described studies, pigs developed clinical disease 
followed by death only in conjunction with a coinfection,7,16 or an immunostimulating 
event.15  In experiments 1, 2, and 3, 2 of 6 pigs inoculated only with PCV2a-688 and 3 of 8 
pigs that received PCV2 and a cofactor were considered to be clinically affected (Table 1).  
All 5 affected pigs from experiments 1 and 3 had similar clinical signs although pig 34B was 
less affected than the others at the time of its scheduled necropsy at 32 dpi.  In addition, all 5 
of these pigs had an abnormal leukogram (beyond 2 standard deviations from the control 
values) for at least one or more of the parameters tested when sampled at necropsy or within 
the previous 2 days.  Except for experiment 3, no known co-factors were given to any of the 
germ-free pigs.  Isolator 33, the control isolator, became contaminated with Chryseomonas 
luteoal with no ill effects noted in the contaminated pigs.  One of the 4 pigs in isolator 34 
inoculated with PCV2 and given an intraperitoneal (ip) injection of FL-KLH was clinically 
affected at 32 dpi, its scheduled necropsy time.  The contributing role of the ip injection is 
not clear since the remaining three isolator pigs were normal in appearance at the time of 
necropsy (32 and 46 dpi).  Likewise, the role the ip FL-KLH injection and colonization with 
E. coli 68 played in the 2 clinically-affected isolator 36 pigs euthanized early (22 and 27 dpi) 
is not clear since the other 2 pigs receiving the same treatment were normal at 46 dpi, their 
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scheduled necropsy time.  The incidence of clinical illness in these “cofactor” groups was 
similar to the incidence in PCV2-only germ-free pigs.18 
One goal of experiments 4 and 5 was to study more closely the kinetics of PCV2 
infection and its effect on the abnormal leukogram through bi-weekly blood sampling. The 
lesions, virus load, and ELISA serology found in these experiments have been reported 
previously.9  WBC counts on serially collected blood samples collected in experiments 4 and 
5 revealed the onset of abnormal N/L ratios beginning by 14 dpi.  Most of the pigs that 
eventually became clinically affected had an abnormal leukogram by 21 dpi.  The early rise 
in N/L ratio was attributed to an absolute lymphopenia creating a relative neutrophilia (data 
not shown).  This was followed by an increasing neutrophil count, producing an absolute 
neutrophilia, especially in clinically-affected pigs.  The onset of lymphopenia following 
PCV2 infection has been reported before and is believed to be directly related to PCV2 
infection.36,37  It is not clear how PCV2-infection plays a role in the neutrophilia reported 
here.  Possible explanations include: 1) The neutrophilia may be an artifact of a PCV2 
infection in germ-free pigs.  However, this phenomenon was also seen in 2 of the 4 isolator 
36 pigs that were colonized with the E. coli 68 strain, an event that activates the germ-free 
pig immune system more typical of conventional pigs.  2) The neutrophilia was a bystander 
effect linked to the severe lymphopenia, inducing a host response to produce more 
lymphocytes and this signal also stimulated abnormal production of neutrophils.  3)  The 
production of neutrophils was normal, but the clearance mechanism/emigration of 
neutrophils was abnormal.  4) The neutrophilia was related to a dysregulated host immune 
response directed against viral and/or host antigens. 
  
87 
 
Based on a lack of clinical disease and the presence of a virus neutralization titer, 
some PCV2-infected pigs in experiment 5 may have developed a protective immune 
response.  An inverse relationship between VNT and clinical disease was found in 12 of the 
14 clinically affected pigs.  A similar relationship was reported previously which compared 
virus load, clinical disease, and ELISA antibody levels in the experiment 4 and 5 PCV2-
infected pigs.9  When comparing clinical and subclinical pigs, pigs that seroconverted were 
less likely to have developed disease and had a lower virus load.  Regardless of the limited 
number of pigs in experiments 4 and 5, there appeared to be a direct relationship between the 
detection of anti-PCV2 IgG and VNT antibody.  Six of the 10 pigs that had detectable virus 
neutralization activity were ELISA positive and pig 53D was suspect ELISA positive.  Pigs 
51B, 53C and 54C had low VNT50 titers and were ELISA negative.  The remaining PCV2-
infected pigs in experiment 5 were negative by both assays. 
Regarding either the development or absence of PCV2 protective immunity, there 
appears to be 3 responses under the conditions of the studies reported here, and previously.9 
The first outcome is that pigs develop ELISA and VNT antibody, have a lower virus load, 
and are subclinically affected  A second outcome occurs with pigs that do not develop 
detectable antibody, have a high virus load, and are clinically affected.  The third outcome is 
a mixed response where pigs have become ELISA or VNT positive, may or may not be 
clinically affected and have a high virus load.  Pigs 53C, 53D, and 54C fall into the third 
outcome. 
The environmental variation is minimized among treatment groups and experiments 
in germ-free pig studies.  In essence, the germ-free pig model can evaluate the host-pathogen 
interaction without environmental influences.  However, one limitation of the model is that 
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the germ-free pig does not have a mature or activated immune system.  This condition may 
exacerbate the actions of a pathogen as seen in this pig model in which 52% of the pigs were 
clinically affected following challenge with PCV2.  This incidence rate is in stark contrast to 
conventionally-raised pigs experimentally infected with PCV2.1,2,13,19,25,31  In addition, 89% 
of the PCV2-infected pigs in the experiments reported here had an abnormal leukogram; 
again a very high incidence rate when compared to the limited studies that have been 
reported for experimentally-infected conventional pigs.  Another limitation of this 
experimental model is the capacity of the isolators restricts the size and duration of the 
experiment to multiples of 4 pigs for roughly 6 weeks.  It is not clear how many more pigs 
might have become clinically affected if allowed to live longer.  For example, based on the 
earliest onset of clinical disease (21 dpi), the 2 pigs euthanized at 11 dpi in experiment 2 
(20B, 20C) likely did not have enough time to develop an abnormal leukogram. Given that 
about half of the pigs developed clinical disease, it is likely that one of these pigs would have 
developed clinical disease had they been allowed to live for another 5 weeks.  Collectively, 
this disease model provides some insight into 1) the span of time between virus challenge 
and development of an abnormal leukogram and subsequent clinical disease, and 2) the 
apparent development of a protective immune response in a portion of the pigs following 
challenge.  
 
 
 
 
 
  
89 
 
Acknowledgments 
 The authors thank S. Pohl, D. Adolphson, D. Alt, K. Halloum, Brian Pottebaum and 
Jason Huegel for technical assistance and S. Ohlendorf and M. Marti for manuscript 
preparation.  This work was funded in part by a National Pork Board grant.  
 
 
 
 
 
  
90 
 
Table 1: Experimental design including the inocula used the total number of pigs per group 
and the number of clinically affected pigs in each group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experiment Controla PCV2ab  
 688 
PCV2ab  NC1 PCV2bb  NC2 
1 0/0 2/2* -- -- 
2 0/4 0/4 -- -- 
3c 0/6 3/8 -- -- 
4 0/4 -- 1/4 4/4 
5 0/4 -- 7/12 7/12 
a - Sham-inoculated control pigs 
b - Virus inoculum 
c - Pigs inoculated with PCV2 and cofactor 
* - Numerator - number of clinically affected pigs 
* - Denominator - number of pigs in experimental groups 
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Table 2: Normal leukogram values and Neutrophil / Lymphocyte (N/L) ratios for all control pigs from 4 experiments
Experiment Pig ID WBC e Neutrophils Lymphocytes Monocytes Eosinophils Basophils N/L Ratio Necropsy dpi
2 21A 4.24 0.48 3.71 0.06 0.00 0.00 0.10 25
2 21B 3.94 0.96 2.92 0.05 0.00 0.00 0.30 11
2 21C 3.54 0.85 2.61 0.07 0.01 0.00 0.30 11
2 21D 2.56 0.69 1.82 0.05 0.00 0.01 0.40 25
4 45A 3.76 1.23 2.51 0.02 0.00 0.00 0.49 23
4 45B 4.00 0.79 3.16 0.05 0.00 0.00 0.25 35
4 45C 6.12 1.57 4.46 0.06 0.04 0.00 0.35 23
4 45D 3.22 0.54 2.52 0.13 0.02 0.01 0.21 35
5 57A 2.38 0.48 1.82 0.07 0.01 0.00 0.26 28
5 57B 5.08 1.28 3.78 0.01 0.01 0.00 0.34 41
5 57C 5.38 1.11 4.23 0.03 0.01 0.00 0.26 41
5 57D 2.40 0.77 1.49 0.08 0.04 0.02 0.48 28
Average a 3.89 (1.19) 0.90 (0.34) 2.92 (0.97) 0.06 (0.03) 0.01 (0.01) 0.003 (0.01) 0.31 (0.11) 27.26 (3.5)
3 33A c 5.12 1.38 3.70 0.02 0.01 0.00 0.40 46
3 33B c 5.72 1.14 4.51 0.06 0.01 0.00 0.40 32
3 33C c 5.56 1.03 4.49 0.04 0.00 0.00 0.20 46
3 33D c 3.28 1.01 2.23 0.02 0.01 0.00 0.50 32
3 35A c 5.40 1.47 3.89 0.03 0.01 0.00 0.40 46
3 35B c 4.44 1.55 2.87 0.02 0.00 0.00 0.50 46
Average b 4.23 (1.19) 1.02 (0.35) 3.15 (0.98) 0.05 (0.03) 0.01 (0.01) 0.002 (0.01) 0.34 (0.12) 28.32 (3.86)
 
 
 
 
 
 
 
 
 
 
 
 
 
Normal leukogram values are reported as actual number in thousands per microliter of whole blood.  Data from experiment 2, 4 and 5 were used to 
establish the normal range and for statistical comparison.  Experiment 3 values were excluded due to differences in treatment.  Experiment 1 did not 
have controls.  Averages for each parameter are listed with standard deviation in (  ). 
a – average of pigs in experiments 2, 4, and 5. 
b – average of pigs in experiments 2, 3, 4, and 5 
c – pigs received fluorescyl-keyhole limpet hemocyanin (FL-KLH) and 
      a bacterial contaminant was isolated at 0 dpi 
d – pigs received FL-KLH and were inoculated with E. coli at 0 dpi 
e – White Blood Cells 
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Table 3: Neutrophil and lymphocyte values and Neutrophil / Lymphocyte (N/L) ratios for PCV2-infected pigs at necropsy.
Clinically Clinically
Experiment Pig ID Affected Neutrophil Lymphocyte N/L Ratio Experiment Pig ID Affected Neutrophil Lymphocyte N/L Ratio
1 14A Yes 8.45 1.21 6.98 5 51C No 1.54 4.16 0.37
1 14D Yes 16.50 0.69 23.91 5 51D Yes 9.33 0.72 12.96
2 20A No 2.08 1.79 1.16 5 52A No 1.58 2.98 0.53
2 20B No 0.90 2.54 0.35 5 52B Yes 1.15 0.40 2.88
2 20C No 0.84 3.00 0.28 5 52C Yes 4.49 0.86 5.22
2 20D No 2.61 3.62 0.72 5 52D Yes 3.91 1.80 2.17
3 34A a No 1.55 5.40 0.29 5 53A Yes 2.15 0.50 4.30
3 34B a Yes 3.51 1.59 2.21 5 53B Yes 2.53 0.57 4.44
3 34C a No 1.80 4.73 0.38 5 53C No 1.22 1.03 1.18
3 34D a No 1.35 2.35 0.57 5 53D Yes 2.25 2.22 1.01
3 36A b No 1.43 4.29 0.33 5 54A No 1.19 1.79 0.66
3 36B b Yes 6.03 0.59 10.22 5 54B No 2.97 3.36 0.88
3 36C b Yes 1.49 1.44 1.03 5 54C Yes 1.55 0.50 3.10
3 36D b No 2.31 4.97 0.46 5 54D Yes 6.06 0.53 11.43
4 46A No 2.23 1.61 1.39 5 55A No 1.91 1.69 1.13
4 46B Yes 12.04 2.18 5.52 5 55B No 2.70 5.60 0.48
4 46C No 2.50 2.73 0.92 5 55C Yes 5.53 0.68 8.13
4 46D No 2.19 2.63 0.83 5 55D No 1.51 4.21 0.36
4 47A Yes 22.49 0.67 33.57 5 56A Yes 3.53 1.07 3.30
4 47B Yes 9.87 0.71 13.90 5 56B No 1.66 1.90 0.87
4 47C Yes 9.38 1.45 6.47 5 56C Yes 3.62 3.40 1.06
4 47D Yes 4.80 1.03 4.66 5 56D Yes 1.63 0.31 5.26
5 51A Yes 2.08 0.72 2.89 Clinical c Average Yes 6.02 1.08 7.36
5 51B No 1.38 0.96 1.44 Subclinical c Average No 1.79 3.06 0.71
 
 
 
 
 
 
 
Actual neutrophil and lymphocyte values in thousands per microliter of whole blood and N/L ratios at necropsy for PCV2-infected pigs.  
Clinically affected pigs are indicated in bold type.   Leukogram and N/L ratios 2 standard deviations above control values were considered 
abnormal. 
a – pigs receiving FL-KLH.   
b – pigs receiving FL-KLH and E. coli. 
c – average values for clinically affected and subclinical pigs from all experiments. 
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Table 4: Neutrophil / Lymphocyte (N/L) ratios at scheduled bleeding times - Experiments 4 - 5
Clinically dpi
Experiment 4 Affected 7 14 24 29 35
46A No 0.35 0.45 1.39 - -
46B Yes 0.42 0.75 3.19 6.29 5.52
46C No 0.28 0.61 0.92 - -
46D No 0.41 0.53 0.71 0.58 0.83
47A Yes 0.44 12.43 33.57 - -
47B Yes 0.34 2.12 13.90 - -
47C Yes 0.34 1.66 3.06 6.47 -
47D Yes 0.34 4.66 7.44 - -
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neutrophil to lymphocyte (N/L) ratios calculated for each scheduled bleeding in 
experiments 4 and 5.  Boxes indicate values at scheduled necropsy.  Values 
without boxes were from pigs euthanized between scheduled bleeding.   
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Table 4 contd:  Neutrophil / Lymphocyte (N/L) ratios at scheduled bleeding times - Experiments 4 - 5
Clinically dpi VNTa 90 / 50
Experiment 5 Affected 14 19 22 26 29 33 36 41 Titers
51A Yes 0.52 3.57 2.89 - - - - - 0 / 0
51B No 0.35 1.32 1.92 1.40 1.44 - - - 0 / 8
51C No 0.42 0.53 0.78 0.69 1.07 0.53 0.46 0.37 128 / 512
51D Yes 2.04 3.67 3.82 4.87 13.59 - - - 0 / 0
52A No 0.50 1.15 1.34 0.79 1.11 0.97 0.74 0.53 8 / 64
52B Yes 0.56 4.64 3.65 - - - - - 0 / 0
52C Yes 0.82 6.39 3.58 - - - - - 0 / 0
52D Yes 0.45 2.34 - - - - - - 0 / 0
53A Yes 0.27 0.37 0.73 2.23 4.30 - - - 0 / 0
53B Yes 0.21 0.45 1.32 2.97 1.95 0.87 1.47 - 0 / 0
53C No 0.24 0.46 0.59 1.10 1.18 - - - 0 / 4
53D Yes 1.43 0.66 0.44 0.40 1.10 1.74 2.00 1.01 16 / 128
54A No 0.23 0.39 0.44 0.58 0.66 - - - 0 / 0
54B No 0.30 0.51 0.73 0.57 0.72 0.76 1.38 0.88 4 / 128
54C Yes 0.26 1.57 2.30 2.21 3.10 - - - 2 / 8
54D Yes 0.33 0.70 0.87 2.72 4.65 12.63 - - 0 / 0
55A No 0.42 0.74 1.07 1.67 1.13 - - - 4 / 64
55B No 0.32 0.40 0.80 0.72 0.54 0.55 0.53 0.48 16 / 1024
55C Yes 3.15 2.32 3.40 8.07 - - - - 0 / 0
55D No 0.54 1.09 2.24 1.51 1.02 0.69 0.67 0.36 16 / 512
56A Yes 0.41 3.11 4.39 5.65 - - - - 0 / 0
56B No 0.35 0.60 0.96 1.72 1.81 1.44 0.93 0.87 0 / 0
56C Yes 0.50 1.58 1.38 - - - - - 0 / 0
56D Yes 0.32 6.45 6.44 4.16 3.51 4.74 4.52 - 0 / 0
Neutrophil to lymphocyte (N/L) ratios calculated for each scheduled bleeding in experiments 4 and 5.  Boxes indicate values at 
scheduled necropsy.  Values without boxes were from pigs euthanized between scheduled bleeding.   
a – Virus neutralization test (VNT) were calculated only for experiment 5.  VNT 90 / 50 – virus neutralization titers reducing PCV2-
infected PK15 cells by 90% (numerator) and by 50% (denominator).   
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CHAPTER 5: GNOTOBIOTIC PIG SUMMARY 
 
 Gnotobiotic (GN) is the term used to describe pigs infected with one or more known 
microorganisms whereas germ-free pigs are devoid of any detectable form of microbiological 
life.  Both systems require stringent testing to prove the absence of microorganisms in the 
germ-free state or a lack of any other life form than those known to be present in the GN pig.  
Conventional pigs contain the undefined population of microorganisms typical for that 
particular species. 
 Gnotobiotic animals are a valuable tool for investigating the host/pathogen 
relationship.  Under these conditions, controlled experiments are not confounded by 
extraneous factors including influences from the host interaction with normal intestinal 
microflora.  The gnotobiotic pig allows an extensive evaluation of specific immune responses 
and the pathology associated with a disease and/or pathogen, as well as microscopic lesions 
that are sometimes caused by the destructive nature of the host inflammatory response.   
 Although a valuable research tool, GN pig studies are generally limited in duration 
due to size constraints imposed by the isolator, allow only a restricted number of 
experimental animals, require strict biosecurity measures to eliminate contamination, and are 
typically expensive.  Modernized techniques and equipment have made the GN process 
easier and less expensive, but few laboratories have chosen this area of research.  
Furthermore, experimental results must be interpreted with caution due to the unique 
physiology of the GN pig and the effect this may have on certain biological parameters. 
 The literature does not contain a recent review of normal hematological values, 
growth rates and general characteristics of GN pigs.  What is available is at least 20 years old 
and does not reflect changes in these parameters that have occurred due to genetics, nutrition 
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and current gnotobiotic methodology.  The following discussion combines both dated and 
recent information regarding normal values for the aforementioned categories.  This 
information is limited and an extensive yet relevant review is needed for each of these areas. 
 The gnotobiotic pig appears to thrive as well as conventional pigs when given an 
adequate diet and environment suitable for neonates.  Table 1 indicates the range of 
temperatures considered suitable for GN pigs within an isolator provided by an external heat 
source.  These values are meant to be used as a guideline to provide the proper environment.  
GN pigs are given a nutritionally sufficient diet although quantities are usually restricted.  
Therefore, average daily gains are typically half of the rate of conventional pigs to allow for 
size restrictions imposed by the dimensions of the isolator.3  Table 2 lists 3 different diets 
which compare the intake of GN pigs fed ad libitum to the quantities utilized in a restricted 
diet.3,4  A diet consisting of condensed cow’s milk was fed ad libitum whereas canned 
condensed milk and a commercially-available pasteurized milk diet (Esbilac® Kansas City, 
KS USA) were given as restricted diets.  GN pigs are typically active immediately before 
feeding with the majority of the time spent in an inactive state, similar to conventional pigs 
of the same age.  Due to the restricted feed intake, GN pigs maintain a vigorous appetite and 
any lack of interest or decrease in feed intake are considered abnormal in this particular 
model.  Table 3 compares growth rates between GN and conventional pigs.3 
 The immune system of GN pigs is less developed than conventional pigs that have 
had immune stimulation through their intestinal microflora.1,5  Reaction centers and 
immunologically competent cells in the lymphatic tissue are rare, but the ability to respond to 
microbial antigens remains comparable, although slightly slower, to conventional pigs.  
Hematological values are somewhat elevated during the first week after birth with a 
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subsequent decline to normal values for GN pigs possibly due to physiological adjustment 
during the postoperational period or a loss of prenatal accumulation of immune cells.2 
 Normal values for various hematology and leukogram parameters for GN pigs from 3 
different studies are reported in Table 4 and 5.  Previous evaluation of different parameters is 
lacking in the literature and is in need of updating, therefore, results are sporadic but included 
for comparison.  GN-1 pigs were given a condensed milk diet,3 GN-2 pigs were given total 
parenteral nutrition formula by intravenous infusion2 and GN-3 reflects values from control 
pigs used in the studies described in Chapter 2 and Chapter 3 of this thesis.  Conventional pig 
1 and 2 values were taken from the GN-1 and GN-2 studies, respectively.  Values were 
included if described in their respective literature, although some values are missing. 
Corresponding ages of the pigs are comparable between groups. 
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Table 1: Isolator temperature recommendations
Gnotobiotic Pigs
Age in Weeks Temperature 0F
1 90-95
2 90
3 85
4 80
5-8 75
8-12 70
 
 
 
 
Table 2: Feeding regimen for gnotobiotic pigs - example of an ad libetum diet vs a restricted intake diet
Ad libitum diet Restricted diet
Condensed milk Condensed milk Esbilac
Age - days ml/day Age - days ml/day ml/day
0-9 300 0-7 180 372
10-13 1125 8-14 270 457
14-23 1350 15-21 360 580
24-33 1575 22-28 450 690
34-43 1800 29-42 540 700
 
 
 
 
Table 3: Growth rates comparing gnotobiotic vs conventional pigs
Body wgt. - kg
Age - weeks Gnotobiotic pigs Conventional pigs
1 1.1 2.7
2 1.4 3.2
3 2 4.8
4 2.8 6.7
5 3.2 7.6
Avg daily gain - grams 73 176
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Table 4: Normal haematology values established for gnotobiotic and conventional pigs
Parameter Age - weeks Gnotobiotic #1 Gnotobiotic #2 Conventional #1 Conventional #2 Reference Values
Haemoglobin, g/dl 0 * 7.8 * * 10 - 16
1 8.8 6.9 7.5 *
2 8.2 7.7 9.7 *
3 7 9.9 9.7 14.5
4 5.9 * 8.7 *
5 5.4 * 7.7 *
Haematocrit % 0 * 26.5 * * 32 - 50
1 27 22.2 22.8 *
2 30 23.7 34.4 *
3 25.6 30.8 29.7 41.1
4 21.6 * 26.6 *
5 18.3 * 24.9 *
Erythrocyte x 106/µl 0 * 4 * * 5 - 8
1 4.1 3.8 4.6 *
2 4.4 4.1 5.8 *
3 4.4 5.5 5.8 7.3
4 4.4 * 6 *
5 4.1 * 6.4 *
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Table 5: Normal leukogram parameters established for gnotobiotic and conventional pigs
Parameter Age - weeks Gnotobiotic #1 Gnotobiotic #2 Gnotobiotic #3 Conventional #1 Conventional #2 Reference Values
Leukocyte x 103/µl 0 * 8.5 5.7 * * 11 - 22
1 4.9 6 4.8 8.6 *
2 8.7 7 4.7 11.3 *
3 6.6 9.3 4.7 13.4 13
4 5.2 * 5.2 8.9 *
5 5.8 * 6.6 9.4 *
PMN % 0 * 52 29.7 * * 28 - 51
1 * 39 30.9 * *
2 * 44 21.4 * *
3 * 49 25.2 * 27
4 * * 24.5 * *
5 * * 22.3 * *
Lymphocytes % 0 * 42 63.2 * * 39 - 62
1 * 59 67.9 * *
2 * 49 75.9 * *
3 * 47 71.9 * 67
4 * * 73.0 * *
5 * * 76.0 * *
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CHAPTER 6: SUMMARY AND CONCLUSIONS 
PCV2a & PCV2b 
 The diagnosis of PCV2b in many U.S swine herds in the fall of 2005 coincided with 
increased mortality suggesting it was a pathogenic subtype of PCV2.3  In addition, PCV2b 
had not been isolated in North America before 2006, which further suggested the emergence 
of a novel PCV2 subtype.  Although differences in pathogenicity have been reported between 
PCV2a isolates,9 it is unknown whether PCV2b is more pathogenic than PCV2a . 
 The purpose of this study was to characterize potential differences between 
gnotobiotic pigs inoculated with PCV2a and PCV2b with emphasis on the clinical signs, 
macroscopic and microscopic lesions, mortality, viremia and development of anti-PCV2 
antibody.  Overall, there were similarities between clinical signs, macroscopic and 
microscopic lesions in clinically affected pigs infected with either subtype.  In addition, there 
were no significant differences between the subtypes regarding mortality, quantity of PCV2 
genomic copies in serum or plasma and the development of anti-PCV2 antibodies.  Although 
it appears these studies do not support pathological differences between PCV2a and PCV2b, 
different quantities of virus were used in the inoculum.  Therefore, an adequate assessment of 
any pathological differences cannot be established and further studies are necessary.   
 Under these experimental conditions, PCV2a and PCV2b were pathogenic in the 
gnotobiotic pig model.  Mortality occurred in 48.1% of the infected pigs, similar to reports 
from field cases that have described severe PCVAD with mortality rates as high as 50%.1,6,7  
PCV2 required approximately 3 weeks before clinical manifestation of the disease and at 
least 50% of the pigs exhibited clinical signs between 23-26 dpi.  Additional trials in our lab 
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using similar virus and dosages produced comparable mortality approximately 3 weeks post 
infection which indicates the clinical effect is reproducible.   
 The onset of clinical signs was sudden and progressed rapidly.  Pigs that appeared 
clinically normal were severely affected in as little as 6 to 10 hours later and there was very 
little variation in clinical signs between severely affected pigs.  Gnotobiotic pigs that are 
healthy possess a vigorous appetite and are active during feeding.  Any degree of lethargy in 
PCV2-infected pigs indicated the initial onset of clinical disease.   Anorexia was followed by 
dyspnea with subsequent death within 12 hours or less.  A loss of appetite, as well as 
leukogram abnormalities (discussed later), became pathognomonic for the development of 
PCVAD.  Interestingly, wasting did not appear to be a common manifestation of PCV2-
infected gnotobiotic pigs.  Although two pigs in the dose titration study developed icterus, 
had pale livers, appeared thin and emaciated but did not die until 34 and 37 dpi.  
Macroscopic lesions were consistent among the dose groups and between genotypes.  
Lungs were diffusely affected with congestion and severe interlobular pulmonary edema.  
Pleural and peritoneal effusions were also present in many of the pigs that became clinically 
affected.  These gross lesions were similar to those reported from cases experiencing high 
mortality in the field.1,6,7  However, the significance of the edema and pleural or peritoneal 
effusions is unknown.  It is possible these lesions are the result of an immune mediated 
response to PCV2-infection similar to a type III hypersensitivity reaction.  Seven of the 
clinically affected pigs did not have effusions in spite of similar clinical signs.  Interestingly, 
these pigs had less severe lung lesions and were designated as having the “dry form” of 
PCVAD as opposed to the “wet” form which was defined as any evidence of effusion or 
edema at necropsy. 
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 The severity of microscopic lesions was not significantly different between pigs 
inoculated with PCV2a or PCV2b.  However, due to size constraints of the isolators, 
gnotobiotic pig studies are typically limited in number of experimental units.  Small sample 
sizes can decrease the statistical power that is necessary to detect significant differences 
between groups.  Therefore, it is difficult to make a conclusive statement regarding 
differences in microscopic lesions between the subtypes until studies can be repeated and 
reevaluated with larger numbers of pigs.  Surprisingly, 2 pigs that were randomly selected for 
necropsy on 28 dpi and 1 pig on 41 dpi had minimal lung lesions.  All 3 pigs were given the 
low dose of virus inoculum and it can be speculated the pigs were euthanized before they had 
time to become clinically affected.  Ironically, 2 of these pigs developed an antibody 
response.  Therefore, it is difficult to predict the clinical outcome in these particular animals. 
 In spite of the different quantities of virus inoculum that was given to pigs within 
their respective dose group, PCV2 titers in plasma or serum of the infected pigs did not show 
any differences during the later stages of the experiment.  Pigs within the PCV2b-L group 
received the lowest quantity of virus and did not have detectable titers until 19dpi compared 
to PCV2a-L pigs which had titers by 14 dpi.  Although it appears it took longer for PCV2b to 
replicate in the pig, there were no differences in PCV2 titers among any of the dose groups 
by 22 dpi.  However, there was a 10-fold difference between the quantity of PCV2a and 
PCV2b in the inoculum and the delayed onset of viremia in the PCV2b-L group could be 
attributed to the quantity of virus in the inoculum rather than differences in genotype. 
 Although PCV2 titers in serum or plasma were similar between dose groups and 
genotypes, there were significant differences between clinically and subclinically affected 
pigs.  Starting by 19 dpi and thereafter, the pigs that became clinically affected had 
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significantly higher virus load in plasma and serum than pigs that remained subclinical.  In 
addition, pigs that did not develop antibody titers to PCV2 (ELISA negative) had 
significantly higher titers in plasma or serum at 26, 29, 33, 36, 41 dpi and when all samples 
were compared at their respective necropsy time.  These results indicate that PCV2 
replication was highest in pigs that developed severe PCVAD and in pigs that lacked an 
antibody response. 
 Four of 8 PCV2a infected pigs seroconverted compared to only 2 of 8 pigs infected 
with PCV2b in the second experiment.  In addition, neutralizing antibodies were detected in 
5 PCV2a-infected pigs and 5 PCV2b-infected pigs in the same trial.  In these studies, pigs 
with PCV2 antibodies were less likely to become clinically affected compared to pigs that 
had no detectable antibody, and was independent of viral genotype. 
PCV2a and PCV2b Combined     
 Significant differences were evident when comparing PCV2-infected pigs that were 
clinically affected and those that remained subclinically infected throughout the trial.  PCV2 
titers in serum were higher in pigs that became clinically affected and in pigs that did not 
develop ELISA or neutralizing antibody.   In addition, these pigs had a more pronounced 
neutrophilia and severe lymphopenia compared to subclinical pigs.  Interestingly, elevated 
neutrophil to lymphocyte ratios were correlated with the presence of clinically affected pigs 
and were significantly different than subclinical pigs starting at 19 dpi.  Interestingly, 2 of the 
3 pigs that were randomly selected for euthanasia at 28 dpi had N/L ratios of 4.3 and 3.1 
lending further support to the possibility these pigs could have become clinical if they had 
been allowed to live for 5 weeks or longer.   
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 PCR results are not a reliable indicator of clinical PCVAD because PCV2 is a 
ubiquitous virus and even healthy pigs are always positive for PCV2 nucleic acid.  However, 
quantitative PCR has been used to predict the clinical outcome of infection. 2,8,10  In the trials 
described here, PCR values equal to or above 8.0 logs of virus per ml of serum were detected 
in clinically affected pigs whereas subclinical pigs had PCV2 genomic copies less than or 
equal to 7.6 logs of virus.  The literature utilizes values of 7.0 logs of virus to predict clinical 
disease and less than 6.0 logs to predict subclinical infection.  Although the PCR values 
dictating these groups in our experiments are somewhat higher, this may reflect the 
physiology of gnotobiotic pigs in which there are fewer constraints on viral replication. 
Although variations in PCR assay and positive standard could affect the results as well.  
Overall, there appeared to be a distinction between the clinical and subclinical groups based 
on quantitative PCR.  Therefore, severe PCVAD may be the result of unregulated replication 
of the virus and PCR values could provide an antemortem indication of the expected clinical 
outcome of infection.  Three pigs that were randomly selected for necropsy had PCV2 
genomic copies above 8.2 logs of virus per ml of serum.  Once again, there is a possibility 
these pigs could have become clinically affected if they had not been euthanized at 28 or 41 
dpi. 
 Approximately 50% of the PCV2-infected pigs were subclinically affected although a 
lymphadenopathy, virus antigen and viremia were detected in these pigs.  Similar to field 
observations, some PCV2-infected pigs appear normal in spite of the presence of severely 
affected cohorts.  Considerable discussion has surrounded this topic and has been the subject 
of investigation.  At this time, it maybe possible an unknown cofactor, either endogenous or 
exogenous, could provide the necessary component which determines whether infection with 
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PCV2 will progress to PCVAD on an individual basis.  An intrinsic host factor, interactions 
with unknown emerging pathogens or immune dysfunction may provide the necessary 
component that allows progression of infection to PCVAD.  Understanding these host 
interactions requires further investigation. 
Coinfection and Immune Stimulation 
 Contrary to previous reports, severe PCVAD was reproduced in the trials described 
here without evidence of a known infectious cofactor.  PCVAD was difficult to 
experimentally reproduce until coinfection with PCV2 and PPV were established as the first 
PMWS model.5  Several subsequent coinfection models are described in the literature which 
correlates severe lesions and PCVAD with the presence of PCV2 and another infectious 
agent or immunostimulating event.  Although we were able to reproduce PCVAD without a 
known infectious cofactor, no claim is made disputing the necessity of some alternative 
factor, other than viral or bacterial, influencing the development of PCVAD.  In addition, 
repeated studies utilizing gnotobiotic pigs have not indicated an immune stimulating event 
associated with husbandry or feeding.  Therefore, gnotobiotic methodology is not likely to be 
a cofactor. 
PCV2 Minimum Infectious Dose  
 The attempt to establish a minimum dose response for PCV2 infection was not 
accomplished.  A delay in the onset of mortality, viremia and development of antibody 
associated with the low dose inoculum in both PCV2a and PCV2b infected pigs suggests a 
trend in which the quantity of virus in the inoculum can influence the time of onset of clinical 
signs.  Beyond 19 dpi, there was no distinction between the different dose groups regarding 
mortality, viremia or lesions in spite of a difference in the quantity of virus in the inoculum.  
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Interestingly, the PCV2 titer in serum and lavage fluid was the highest, 12.6 logs per ml of 
serum or BALF, in a pig in the low dose group inoculated with PCV2a.   
 Pigs that were inoculated with less than one IHC unit per ml of PCV2b in the low 
dose group subsequently developed high titers in their serum.  Although it appeared pigs 
within this group were inoculated with less than 1 infectious virion, we assume this quantity 
was higher than indicated by the IHC method used for titration.  Therefore, the sensitivity of 
the IHC test is questionable.  PCV2 does not produce a cytopathic effect.  Therefore, our 
titrations relied on a technique in which virus-infected PK15 cells are identified through 
chemiluminesence designated as IHC units per ml of inoculum.  Pigs that received 0.85 IHC 
units per ml in the second study developed comparable PCV2 titers in serum to pigs 
receiving a quantity of virus 10,000 times greater.  Quantitative PCR for PCV2 genomic 
copies in the inoculum suggested the presence of larger quantities of virus than detected 
through the IHC technique.  Although PCR is more sensitive, quantities of PCV2 DNA are 
not suggestive of actual infectious virus due to unpackaged viral genomes and residual DNA 
from the transfection process.  PCR was useful in confirming the accuracy of the dilutions 
used in the inoculum, but the true infectious dose probably lies within a range between those 
indicated by the IHC test and quantitative PCR.  Utilizing a PK15 cell line more permissive 
to PCV2 infection would increase the sensitivity of the IHC test.12  In addition, dosage 
effects based on dilutions quantified by PCR would allow accurate comparisons between 
trials due to the precision of PCR testing. 
Leukogram Abnormalities 
 Neutrophil values were consistently elevated in PCV2-infected pigs.  Although a 
lymphopenia is commonly reported, the neutrophilia was unexpected.  Gnotobiotic pigs 
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infected with PCV2 in trials conducted at NADC, but not described in this thesis, also 
developed a neutrophilia, which was considered insignificant at that time.  When these 
experiments were repeated, the neutrophilia became a common manifestation of PCV2-
infected gnotobiotic pigs.  We assume the increased neutrophil response was induced by 
PCV2 infection because no other pathogens were detected. 
 Elevated neutrophils are not a typical response of viral infections.  The host response 
to infection relies on the initial function of the innate immune system to recognize pathogens 
that have breached external barriers.  The innate immune system is non-specific and relies on 
pattern recognition receptors to recognize pattern-associated molecular patterns (PAMPS) on 
the surface of pathogens, which are components conserved among many microorganisms.  
When innate immune cells are unable to control an infection, the adaptive immune response 
becomes activated.   
 The cellular response to infection varies according to the type of microorganism and 
its interaction with the host.  Chemoattractants released by rapidly dividing, pyogenic 
bacteria (typically extracellular gram-positive cocci and gram-negative rods) will evoke a 
suppurative inflammatory immune response predominantly of neutrophils.4  
Chemoattractants include bacterial peptides that are recognized by specific receptors on 
neutrophils.  In addition, bacterial endotoxin stimulates macrophages to release cytokines, 
interleukin-1 and tumor necrosis factor, as well as cleaving complement into peptides which 
can attract neutrophils to the site of infection. 
 Neutrophils are rarely a major component of immune responses to viral or 
intracellular bacterial infections.  These pathogens lack PAMPS for innate immune 
recognition or are obscured from recognition because of their intracellular nature.  
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Neutrophils control infection through many different methods particularly phagocytosing and 
eliminating microorganisms.  In addition, novel functions for neutrophil responses have been 
recently identified.  Small populations of mammalian neutrophils have been shown to 
express a T-cell based immunoreceptor.11  Activation of the neutrophil T-cell receptor (TCR) 
increases the self-secretion of interleukin 8 (IL8) and inhibits apoptosis; ensuring an 
increased lifespan of the neutrophil.11  The induction of IL-8 through the neutrophil TCR 
may rapidly boost the recruitment of additional neutrophils to sites of infection and provides 
a rapid method of antigen-specific defense; although the exact biological role of the 
neutrophil TCR needs further study. 
 Viruses and intracellular bacteria, as well as other intracellular parasites, induce a 
diffuse inflammatory response predominantly composed of mononuclear infiltrates.  Slow 
dividing infectious agents or those of relatively large size usually evoke a granulomatous 
inflammatory response either around a focus of necrotic debris or through the formation of 
giant cells.  Cell-mediated immunity against these pathogens or pathogen-infected cells is 
characterized as lymphocytic responses.4 
 Previous studies have not reported a neutrophilia associated with PCV2-infection in 
controlled experiments.  In contrast, evaluations of blood samples from field cases have 
indicated a neutrophilia.  Accurate conclusions cannot be made from field studies since they 
can be confounded by uncontrolled factors, i.e. unknown pathogens, timing of infection and 
flaws in their experimental design.  The gnotobiotic pig model indicated a consistent 
correlation between an absolute neutrophilia and lymphopenia with the development of 
PCVAD when compared to control pigs.  An abnormal neutrophil to lymphocyte ratio above 
a 3.0 became pathognomonic for severe PCVAD if pigs were not euthanized too early in the 
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course of the infection.  The neutrophil to lymphocyte ratio could provide an additional 
antemortem test for predicting the clinical outcome of PCV2-infected pigs. 
 It is uncertain what role the neutrophils fulfill in the pathogenesis of PCV2 and 
PCVAD.  PCV2-induced lesions described as vasculitis or glomerulonephritis are thought to 
be a type III immune mediated response and neutrophils have been identified in the glomeruli 
in pigs with PDNS.  The lung lesions observed in these pigs could also be related to an 
immune mediated event, but neutrophils are not a common histological feature in the lungs 
of PCV2-infected gnotobiotic pigs.  The neutrophilia maybe a unique response of gnotobiotic 
pigs to a viral infection or the result of overproduction by the bone marrow in response to 
stimuli from cytokines yet to be identified. 
Immunology 
 Pigs that developed a total and or neutralizing antibody response to PCV2 did not 
become clinically affected, had lower PCV2 titers in serum and lavage fluid, and fewer 
leukogram abnormalities than pigs that developed PCVAD.  Although some pigs remained 
normal throughout the trial and did not develop antibodies, it is possible they were 
euthanized too early for a response to occur.  In addition, some pigs that were euthanized 
midway through the trial appeared clinically normal, but contained lesions and may have 
developed PCVAD if they had been allowed to survive.  It appears that immune dysfunction 
could play a significant role in the development of PCVAD.    
General Comments  
 Although it appears there were no differences between PCV2a and PCV2b regarding 
the specific parameters that were tested in these trials (mortality, lesions, PCV2 titers in 
plasma and/or serum, and leukogram abnormalities) the inconsistency between inoculums 
  
115 
 
used in the dose titration study makes it impossible to compare the pathogenesis between the 
two genotypes.  Furthermore, it is necessary to understand the host-pathogen response that 
allows some pigs to remain subclinical whereas others develop severe disease.  Investigations 
in to the molecular structure of PCV2a and PCV2b and mechanisms that go beyond 
pathogenesis studies are necessary to identify possible differences between these two viruses. 
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CHAPTER 6: ABBREVIATIONS 
 
 
 
ANOVA Analysis of Variance
APC Antigen Presenting Cell
BALF Bronchoalveolar Lavage Fluid
bp Base Pairs
BT Bovine Turbinate
BVDV Bovine Viral Diarrhea Virus
cap Capsid
CDCD Cesarian Derived Colostrum Deprived
ConA Concanavalin A
DP Double Positive
dpi Days Post Infection
ELISA Enzyme-Linked Immunosorbent Assay
GN Gnotobiotic
H&E Hematoxalin and Eosin
IFA Indirect Flourescent Antibody
IFN Interferon
IHC Immunohistochemistry
IL8 Interleukin 8
IPMA Immunoperoxidase Monolayer Assay
ISH In Situ Hybridization
JMP Jump
KLH/ICFAKeyhole Limpet Hemocyanin Incomplete Freund's Adjuvant
N/Y Neutrophil to Lymphocyte
NADC National Animal Disease Center
NAHMS National Animal Health Monitoring System
NCBI National Center for Biotechnology Information
NK Natural Killer
ORF2 Open Reading Frame 2
PAMPS Pattern-Associated Molecular Patterns
PBMC Peripheral Blood Mononuclear Cell
PCV: Porcine Circovirus
PCV1: Porcine Circovirus type 1
PCV2: Porcine Circovirus type 2
PCV2a Porcine Circovirus type 2a
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PCV2b Porcine Circovirus type 2b
PCVAD: Porcine circovirus associated disease
PDNS Porcine Dermatitis and Nephropathy Syndrome
PHEV Porcine Hepatitis E Virus
PID Pig Infectious Dose
PMWS: Post-weaning multisystemic wasting syndrome
PPV Porcine Parvovirus
PRRS Porcine Reproductive and Respiratory System
PYG Peptone/Yeast/Glucose
rep Replicase
RFLP Restriction Fragment Length Polymorphism
S/P Sample to Positive Ratio
SIV Swine Influenza Virus
SPF Specific Pathogen Free
TCR T-Cell Receptor
TNF Tumor Necrosis Factor
TSB Trypticase Soy Broth
VN Virus Neutralization
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